Retinoic	O
acid	O
downmodulates	O
erythroid	O
differentiation	O
and	O
GATA1	B-protein
expression	O
in	O
purified	B-cell_line
adult-progenitor	I-cell_line
culture	I-cell_line
.	O

All-trans	O
retinoic	O
acid	O
(	O
RA	O
)	O
is	O
an	O
important	O
morphogen	O
in	O
vertebrate	O
development	O
,	O
a	O
normal	O
constituent	O
in	O
human	O
adult	O
blood	O
and	O
is	O
also	O
involved	O
in	O
the	O
control	O
of	O
cell	O
growth	O
and	O
differentiation	O
in	O
acute	O
promyelocytic	O
leukemia	O
.	O

We	O
have	O
examined	O
the	O
effects	O
of	O
RA	O
on	O
normal	O
hematopoiesis	O
by	O
using	O
early	O
hematopoietic	B-cell_type
progenitor	I-cell_type
cells	I-cell_type
(	O
HPC	B-cell_type
)	O
stringently	O
purified	O
from	O
adult	O
peripheral	O
blood	O
.	O

In	O
clonogenetic	B-cell_line
fetal	I-cell_line
calf	I-cell_line
serum-supplemented	I-cell_line
(	I-cell_line
FCS+	I-cell_line
)	I-cell_line
or	I-cell_line
-nonsupplemented	I-cell_line
(	I-cell_line
FCS-	I-cell_line
)	I-cell_line
culture	I-cell_line
treated	O
with	O
saturating	O
levels	O
of	O
interleukin-3	B-protein
(	O
IL-3	B-protein
)	O
granulocyte-macrophage	B-protein
colony-stimulating	I-protein
factor	I-protein
(	O
GM-CSF	B-protein
)	O
and	O
erythropoietin	B-protein
(	O
Ep	B-protein
)	O
(	O
combined	O
with	O
c-kit	B-protein
ligand	O
in	O
FCS	O
(	O
-	O
)	O
-culture	O
conditions	O
)	O
,	O
RA	O
induces	O
a	O
dramatic	O
dose-dependent	O
shift	O
from	O
erythroid	O
to	O
granulomonocytic	O
colony	O
formation	O
,	O
the	O
latter	O
colonies	O
being	O
essentially	O
represented	O
by	O
granulocytic	B-cell_line
clones	I-cell_line
.	O

This	O
shift	O
is	O
apparently	O
not	O
caused	O
by	O
a	O
recruitment	O
phenomenon	O
,	O
because	O
in	O
FCS+	B-cell_line
culture	I-cell_line
,	O
the	O
total	O
number	O
of	O
colonies	O
is	O
not	O
significantly	O
modified	O
by	O
RA	O
addition	O
.	O

In	O
FCS-	B-cell_line
liquid-suspension	I-cell_line
culture	I-cell_line
supplemented	O
with	O
saturating	O
Ep	B-protein
level	O
and	O
low-dose	B-protein
IL-3/GM-CSF	I-protein
,	O
adult	O
HPC	B-cell_type
undergo	O
unilineage	O
erythropoietic	O
differentiation	O
:	O
Here	O
again	O
,	O
treatment	O
with	O
high-dose	O
RA	O
induces	O
a	O
shift	O
from	O
the	O
erythroid	O
to	O
granulocytic	O
differentiation	O
pathway	O
.	O

Studies	O
on	O
RA	O
time-response	O
or	O
pulse	O
treatment	O
in	O
semisolid	O
or	O
liquid	O
culture	O
show	O
that	O
early	O
RA	O
addition	O
is	O
most	O
effective	O
,	O
thus	O
indicating	O
that	O
early	O
but	O
not	O
late	O
HPC	B-cell_type
are	O
sensitive	O
to	O
its	O
action	O
.	O

We	O
then	O
analyzed	O
the	O
expression	O
of	O
the	O
master	B-DNA
GATA1	I-DNA
gene	I-DNA
,	O
which	O
encodes	O
a	O
finger	B-protein
transcription	I-protein
factor	I-protein
required	O
for	O
normal	O
erythroid	O
development	O
;	O
addition	O
of	O
RA	O
to	O
HPC	B-cell_type
stimulated	O
into	O
unilineage	O
erythropoietic	O
differentiation	O
in	O
liquid	O
culture	O
caused	O
a	O
virtually	O
complete	O
inhibition	O
of	O
GATA1	B-RNA
mRNA	I-RNA
induction	O
.	O

These	O
results	O
indicate	O
that	O
RA	O
directly	O
inhibits	O
the	O
erythroid	O
differentiation	O
program	O
at	O
the	O
level	O
of	O
early	O
adult	O
HPC	B-cell_type
,	O
and	O
may	O
lead	O
to	O
a	O
shift	O
from	O
the	O
erythroid	O
to	O
granulocytic	O
differentiation	O
pathway	O
.	O

This	O
phenomenon	O
is	O
correlated	O
with	O
inhibition	O
of	O
GATA1	B-protein
induction	O
in	O
the	O
early	O
stages	O
of	O
erythropoietic	O
differentiation	O
.	O

From	NULL
www.bloodjournal.org	NULL
by	NULL
guest	NULL
on	NULL
May	NULL
10	NULL
,	NULL
2019	NULL
.	NULL

For	NULL
personal	NULL
use	NULL
only	NULL
.	NULL

Retinoic	NULL
Acid	NULL
Downmodulates	NULL
Erythroid	NULL
Differentiation	NULL
and	NULL
GA	NULL
TALI	NULL
Expression	NULL
in	NULL
Purified	NULL
Adult-Progenitor	NULL
Culture	NULL
By	NULL
C.	NULL
Labbaye	NULL
,	NULL
M.	NULL
Valtieri	NULL
,	NULL
U.	NULL
Testa	NULL
,	NULL
A.	NULL
Giampaolo	NULL
,	NULL
E.	NULL
Meccia	NULL
,	NULL
P.	NULL
Sterpetti	NULL
,	NULL
I.	NULL
Paroltini	NULL
,	NULL
E.	NULL
Pelosi	NULL
,	NULL
D.	NULL
Buigarini	NULL
,	NULL
Y.E	NULL
.	NULL

Cayre	NULL
,	NULL
and	NULL
C.	NULL
Peschle	NULL
All-trans	NULL
retinoic	NULL
acid	NULL
(	NULL
RA	NULL
)	NULL
is	NULL
an	NULL
important	NULL
morphogen	NULL
in	NULL
vertebrate	NULL
development	NULL
,	NULL
a	NULL
normal	NULL
constituent	NULL
in	NULL
human	NULL
adult	NULL
blood	NULL
and	NULL
is	NULL
also	NULL
involved	NULL
in	NULL
the	NULL
control	NULL
of	NULL
cell	NULL
growth	NULL
and	NULL
differentiation	NULL
in	NULL
acute	NULL
promyelocytic	NULL
leukemia	NULL
.	NULL

We	NULL
have	NULL
examined	NULL
the	NULL
effects	NULL
of	NULL
RA	NULL
on	NULL
normal	NULL
hematopoiesis	NULL
by	NULL
using	NULL
early	NULL
hematopoietic	NULL
progenitor	NULL
cells	NULL
(	NULL
HPC	NULL
)	NULL
stringently	NULL
purified	NULL
from	NULL
adult	NULL
peripheral	NULL
blood	NULL
.	NULL

In	NULL
clonogenetic	NULL
fetal	NULL
calf	NULL
serum-supplemented	NULL
(	NULL
FCS*	NULL
)	NULL
or	NULL
-nonsupple-mented	NULL
(	NULL
FCS	NULL
~	NULL
)	NULL
culture	NULL
treated	NULL
with	NULL
saturating	NULL
levels	NULL
of	NULL
in-terleukin-3	NULL
(	NULL
IL-3	NULL
)	NULL
granulocyte-macrophage	NULL
colony-stimulating	NULL
factor	NULL
(	NULL
GM-CSF	NULL
)	NULL
and	NULL
erythropoietin	NULL
(	NULL
Ep	NULL
)	NULL
(	NULL
combined	NULL
with	NULL
c-kit	NULL
ligand	NULL
in	NULL
FCS	NULL
~-culture	NULL
conditions	NULL
}	NULL
,	NULL
RA	NULL
induces	NULL
a	NULL
dramatic	NULL
dose-dependent	NULL
shift	NULL
from	NULL
erythroid	NULL
to	NULL
granulomonocytic	NULL
colony	NULL
formation	NULL
,	NULL
the	NULL
latter	NULL
colonies	NULL
being	NULL
essentially	NULL
represented	NULL
by	NULL
granulocytic	NULL
clones	NULL
.	NULL

This	NULL
shift	NULL
is	NULL
apparently	NULL
not	NULL
caused	NULL
by	NULL
a	NULL
recruitment	NULL
phenomenon	NULL
,	NULL
because	NULL
in	NULL
FCS	NULL
*	NULL
culture	NULL
,	NULL
the	NULL
total	NULL
number	NULL
of	NULL
colonies	NULL
is	NULL
not	NULL
significantly	NULL
modified	NULL
by	NULL
RA	NULL
addition	NULL
.	NULL

In	NULL
FCS~	NULL
liquid-suspension	NULL
culture	NULL
supplemented	NULL
with	NULL
saturating	NULL
Ep	NULL
level	NULL
and	NULL
LL-TRANS	NULL
RETINOIC	NULL
ACID	NULL
(	NULL
RA	NULL
)	NULL
and	NULL
other	NULL
synthetic	NULL
analogues	NULL
are	NULL
important	NULL
morphogens	NULL
in	NULL
avian/	NULL
mammalian	NULL
development	NULL
:	NULL
(	NULL
1	NULL
)	NULL
in	NULL
chick	NULL
embryonal	NULL
limbs	NULL
,	NULL
endogenous	NULL
RA	NULL
gradients	NULL
underlie	NULL
pattern	NULL
formation	NULL
,	NULL
and	NULL
(	NULL
2	NULL
)	NULL
in	NULL
mouse	NULL
embryos	NULL
,	NULL
perturbation	NULL
of	NULL
RA	NULL
concentrations	NULL
leads	NULL
to	NULL
disruptive	NULL
morphologic	NULL
alterations	NULL
,	NULL
as	NULL
well	NULL
as	NULL
to	NULL
ho-meotic	NULL
transformations	NULL
.	NULL
``	NULL

Furthermore	NULL
,	NULL
RA	NULL
induces	NULL
in	NULL
vi-tro	NULL
differentiation	NULL
of	NULL
human	NULL
teratocarcinoma	NULL
cells	NULL
and	NULL
coordinate	NULL
expression	NULL
of	NULL
homeobox-containing	NULL
genes	NULL
.	NULL

!	NULL

RA	NULL
also	NULL
affects	NULL
differentiation	NULL
of	NULL
neoplastic	NULL
and	NULL
normal	NULL
hematopoietic	NULL
cells	NULL
.	NULL

In	NULL
this	NULL
regard	NULL
,	NULL
RA	NULL
induces	NULL
granulocytic	NULL
differentiation	NULL
of	NULL
acute	NULL
myeloblastic	NULL
and	NULL
promyelocytic	NULL
leukemia	NULL
(	NULL
AML	NULL
,	NULL
APL	NULL
)	NULL
cell	NULL
lines	NULL
(	NULL
eg	NULL
,	NULL
HL-60	NULL
,	NULL
NB4	NULL
,	NULL
AML-193	NULL
)	NULL
*	NULL
as	NULL
well	NULL
as	NULL
APL	NULL
blasts	NULL
in	NULL
vivo	NULL
.	NULL
``	NULL

Studies	NULL
on	NULL
normal	NULL
hematopoietic	NULL
cells	NULL
indicated	NULL
that	NULL
RA	NULL
stimulates	NULL
the	NULL
clonal	NULL
growth	NULL
of	NULL
normal	NULL
human	NULL
granulo-monocytic	NULL
progenitors	NULL
colony-forming	NULL
unit-granulocyte-macrophage	NULL
[	NULL
CFU-GM	NULL
]	NULL
,	NULL
'	NULL
whereas	NULL
the	NULL
RA	NULL
effect	NULL
on	NULL
erythroid	NULL
progenitor	NULL
growth	NULL
was	NULL
reportedly	NULL
stimulatory	NULL
in	NULL
the	NULL
human®	NULL
and	NULL
inhibitory	NULL
in	NULL
the	NULL
avian	NULL
'	NULL
species	NULL
.	NULL

The	NULL
significance	NULL
of	NULL
these	NULL
different	NULL
results	NULL
on	NULL
erythroid	NULL
progenitors	NULL
is	NULL
uncertain	NULL
,	NULL
because	NULL
the	NULL
above-mentioned	NULL
studies	NULL
were	NULL
performed	NULL
not	NULL
only	NULL
on	NULL
different	NULL
species	NULL
,	NULL
but	NULL
also	NULL
with	NULL
different	NULL
RA	NULL
dosages	NULL
and	NULL
on	NULL
unpuri-fied	NULL
bone	NULL
marrow	NULL
(	NULL
BM	NULL
)	NULL
hematopoietic	NULL
progenitor	NULL
cells	NULL
(	NULL
HPCs	NULL
)	NULL
(	NULL
the	NULL
coplated	NULL
accessory	NULL
cells	NULL
may	NULL
modify	NULL
RA	NULL
me-tabolism	NULL
,	NULL
and	NULL
release	NULL
in	NULL
culture	NULL
a	NULL
variety	NULL
of	NULL
growth	NULL
factors	NULL
.	NULL
``	NULL

''	NULL
Interestingly	NULL
,	NULL
RA	NULL
is	NULL
an	NULL
important	NULL
cofactor	NULL
in	NULL
T-lymphocyte	NULL
proliferation	NULL
,	NULL
``	NULL
as	NULL
well	NULL
as	NULL
in	NULL
B-lymphocyte	NULL
proliferation	NULL
and/or	NULL
differentiation	NULL
.	NULL

'*'*	NULL
We	NULL
have	NULL
analyzed	NULL
the	NULL
effects	NULL
of	NULL
RA	NULL
on	NULL
normal	NULL
HPCs	NULL
stringently	NULL
purified	NULL
from	NULL
adult	NULL
peripheral	NULL
blood	NULL
(	NULL
PB	NULL
)	NULL
.	NULL

The	NULL
results	NULL
indicate	NULL
that	NULL
RA	NULL
induces	NULL
a	NULL
dose-related	NULL
inhibitory	NULL
effect	NULL
on	NULL
the	NULL
erythroid	NULL
differentiation	NULL
of	NULL
early	NULL
HPCs	NULL
,	NULL
possibly	NULL
via	NULL
suppression	NULL
of	NULL
GATA	NULL
]	NULL
gene	NULL
induction	NULL
.	NULL

MATERIALS	NULL
AND	NULL
METHODS	NULL
Hematopoietic	NULL
growth	NULL
factors	NULL
and	NULL
chemical	NULL
inducer	NULL
.	NULL

-	NULL
Recombi-nant	NULL
human	NULL
IL-3	NULL
(	NULL
rhIL-3	NULL
)	NULL
and	NULL
rhGM-CSF	NULL
(	NULL
1.7	NULL
to	NULL
2.5	NULL
x	NULL
10	NULL
``	NULL
U/mg	NULL
)	NULL
Blood	NULL
,	NULL
Vol	NULL
83	NULL
,	NULL
No	NULL
3	NULL
(	NULL
February	NULL
1	NULL
)	NULL
,	NULL
1994	NULL
:	NULL
pp	NULL
651-656	NULL
low-dose	NULL
IL-3/GM-CSF	NULL
,	NULL
adult	NULL
HPC	NULL
undergo	NULL
unilineage	NULL
erythropoietic	NULL
differentiation	NULL
:	NULL
Here	NULL
again	NULL
,	NULL
treatment	NULL
with	NULL
high-dose	NULL
RA	NULL
induces	NULL
a	NULL
shift	NULL
from	NULL
the	NULL
erythroid	NULL
to	NULL
granulocytic	NULL
differentiation	NULL
pathway	NULL
.	NULL

Studies	NULL
on	NULL
RA	NULL
time-response	NULL
or	NULL
pulse	NULL
treatment	NULL
in	NULL
semisolid	NULL
or	NULL
liquid	NULL
culture	NULL
show	NULL
that	NULL
early	NULL
RA	NULL
addition	NULL
is	NULL
most	NULL
effective	NULL
,	NULL
thus	NULL
indicating	NULL
that	NULL
early	NULL
but	NULL
not	NULL
late	NULL
HPC	NULL
are	NULL
sensitive	NULL
to	NULL
its	NULL
action	NULL
.	NULL

We	NULL
then	NULL
analyzed	NULL
the	NULL
expression	NULL
of	NULL
the	NULL
master	NULL
GATA	NULL
!	NULL

gene	NULL
,	NULL
which	NULL
encodes	NULL
a	NULL
finger	NULL
transcription	NULL
factor	NULL
required	NULL
for	NULL
normal	NULL
erythroid	NULL
development	NULL
;	NULL
addition	NULL
of	NULL
RA	NULL
to	NULL
HPC	NULL
stimulated	NULL
into	NULL
unilineage	NULL
erythropoietic	NULL
differentiation	NULL
in	NULL
liquid	NULL
culture	NULL
caused	NULL
a	NULL
virtually	NULL
complete	NULL
inhibition	NULL
of	NULL
GATA	NULL
!	NULL

mRNA	NULL
induction	NULL
.	NULL

These	NULL
results	NULL
indicate	NULL
that	NULL
RA	NULL
directly	NULL
inhibits	NULL
the	NULL
erythroid	NULL
differentiation	NULL
program	NULL
at	NULL
the	NULL
level	NULL
of	NULL
early	NULL
adult	NULL
HPC	NULL
,	NULL
and	NULL
may	NULL
lead	NULL
to	NULL
a	NULL
shift	NULL
from	NULL
the	NULL
erythroid	NULL
to	NULL
granulocytic	NULL
differentiation	NULL
pathway	NULL
.	NULL

This	NULL
phenomenon	NULL
is	NULL
correlated	NULL
with	NULL
inhibition	NULL
of	NULL
GATA	NULL
?	NULL

induction	NULL
in	NULL
the	NULL
early	NULL
stages	NULL
of	NULL
erythropoietic	NULL
differentiation	NULL
.	NULL

©	NULL
1994	NULL
by	NULL
The	NULL
American	NULL
Society	NULL
of	NULL
Hematology	NULL
.	NULL

were	NULL
supplied	NULL
by	NULL
the	NULL
Genetics	NULL
Institute	NULL
(	NULL
Cambridge	NULL
,	NULL
MA	NULL
)	NULL
,	NULL
rthEp	NULL
and	NULL
rh	NULL
kit	NULL
ligand	NULL
(	NULL
rhKL	NULL
)	NULL
by	NULL
Amgen	NULL
(	NULL
Thousand	NULL
Oaks	NULL
,	NULL
CA	NULL
)	NULL
and	NULL
Immunex	NULL
(	NULL
Seattle	NULL
,	NULL
WA	NULL
)	NULL
,	NULL
respectively	NULL
.	NULL

All-trans	NULL
RA	NULL
was	NULL
obtained	NULL
from	NULL
Sigma	NULL
(	NULL
St	NULL
Louis	NULL
,	NULL
MO	NULL
)	NULL
.	NULL

Adult	NULL
PB	NULL
.	NULL

Adult	NULL
PB	NULL
was	NULL
obtained	NULL
from	NULL
20-	NULL
to	NULL
40-year-old	NULL
healthy	NULL
male	NULL
donors	NULL
after	NULL
informed	NULL
consent	NULL
.	NULL

Blood	NULL
(	NULL
450	NULL
mL	NULL
+	NULL
10	NULL
%	NULL
)	NULL
was	NULL
collected	NULL
in	NULL
preservative-free	NULL
citrate-phosphate-dextrose-ade-nine	NULL
(	NULL
CPDA-1	NULL
)	NULL
anticoagulant	NULL
.	NULL

A	NULL
buffy	NULL
coat	NULL
was	NULL
obtained	NULL
by	NULL
centrifugation	NULL
(	NULL
Beckman	NULL
J6M/E	NULL
,	NULL
1,400	NULL
rpm/20	NULL
minutes	NULL
at	NULL
room	NULL
temper-ature	NULL
;	NULL
Beckman	NULL
Instruments	NULL
,	NULL
Irvine	NULL
,	NULL
CA	NULL
)	NULL
.	NULL

HPC	NULL
purification	NULL
.	NULL

-	NULL
Adult	NULL
PB	NULL
HPCs	NULL
were	NULL
purified	NULL
according	NULL
to	NULL
a	NULL
slight	NULL
modification	NULL
of	NULL
the	NULL
method	NULL
reported	NULL
previously	NULL
.	NULL
``	NULL

''	NULL
Briefly	NULL
,	NULL
(	NULL
1	NULL
)	NULL
PB	NULL
samples	NULL
were	NULL
separated	NULL
over	NULL
a	NULL
Ficoll-Hypaque	NULL
density	NULL
gradient	NULL
(	NULL
density	NULL
[	NULL
d	NULL
]	NULL
,	NULL
1.077	NULL
)	NULL
(	NULL
Pharmacia	NULL
Fine	NULL
Chemicals	NULL
,	NULL
Piscataway	NULL
,	NULL
NJ	NULL
)	NULL
``	NULL
;	NULL
(	NULL
2	NULL
)	NULL
PB	NULL
mononuclear	NULL
cells	NULL
resuspended	NULL
in	NULL
Iscove	NULL
's	NULL
Modified	NULL
Dulbec-co	NULL
's	NULL
Medium	NULL
(	NULL
IMDM	NULL
)	NULL
containing	NULL
20	NULL
%	NULL
heat-inactivated	NULL
FCS	NULL
(	NULL
GIBCO	NULL
,	NULL
Grand	NULL
Island	NULL
,	NULL
NY	NULL
)	NULL
were	NULL
treated	NULL
with	NULL
three	NULL
cycles	NULL
of	NULL
plastic	NULL
adherence	NULL
;	NULL
(	NULL
3	NULL
)	NULL
cells	NULL
were	NULL
separated	NULL
by	NULL
centrifugation	NULL
on	NULL
a	NULL
discontinuous	NULL
Percoll	NULL
(	NULL
Biochrom	NULL
KG	NULL
,	NULL
Berlin	NULL
,	NULL
Germany	NULL
)	NULL
four-step	NULL
gradient	NULL
(	NULL
d	NULL
,	NULL
1.052	NULL
,	NULL
1.056	NULL
,	NULL
1.060	NULL
,	NULL
1.065	NULL
)	NULL
;	NULL
and	NULL
(	NULL
4	NULL
)	NULL
step	NULL
3	NULL
purification	NULL
(	NULL
IIIP	NULL
)	NULL
was	NULL
potentiated	NULL
as	NULL
follows	NULL
:	NULL
low-density	NULL
cells	NULL
(	NULL
1.052	NULL
and	NULL
1.056	NULL
frac-	NULL
From	NULL
the	NULL
Thomas	NULL
Jefferson	NULL
Cancer	NULL
Institute	NULL
,	NULL
Thomas	NULL
Jefferson	NULL
University	NULL
,	NULL
Philadelphia	NULL
,	NULL
PA	NULL
;	NULL
the	NULL
Department	NULL
of	NULL
Hematology-On-cology	NULL
,	NULL
Istituto	NULL
Superiore	NULL
di	NULL
Sanita	NULL
,	NULL
Rome	NULL
,	NULL
Italy	NULL
;	NULL
and	NULL
the	NULL
Department	NULL
of	NULL
Hematology	NULL
,	NULL
Hopital	NULL
Saint	NULL
Antoine	NULL
,	NULL
Paris	NULL
,	NULL
France	NULL
.	NULL

Submitted	NULL
June	NULL
22	NULL
,	NULL
1993	NULL
;	NULL
accepted	NULL
September	NULL
21	NULL
,	NULL
1993	NULL
.	NULL

Supported	NULL
in	NULL
part	NULL
by	NULL
Programma	NULL
Italia-USA	NULL
sulla	NULL
Terapia	NULL
dei	NULL
Tumori	NULL
,	NULL
Istituto	NULL
Superiore	NULL
di	NULL
Sanita	NULL
,	NULL
Rome	NULL
,	NULL
Italy	NULL
,	NULL
a	NULL
National	NULL
Institutes	NULL
of	NULL
Health	NULL
Grant	NULL
(	NULL
CA	NULL
43225-07	NULL
to	NULL
YEC	NULL
)	NULL
,	NULL
and	NULL
a	NULL
grant	NULL
from	NULL
the	NULL
William	NULL
J.	NULL
Matheson	NULL
Foundation	NULL
.	NULL

Address	NULL
reprint	NULL
requests	NULL
to	NULL
C.	NULL
Peschle	NULL
,	NULL
MD	NULL
,	NULL
Thomas	NULL
Jefferson	NULL
Cancer	NULL
Institute	NULL
,	NULL
Bluemle	NULL
Life	NULL
Sciences	NULL
Bldg	NULL
,	NULL
Room	NULL
528	NULL
,	NULL
Thomas	NULL
Jefferson	NULL
University	NULL
,	NULL
233	NULL
S	NULL
10th	NULL
St	NULL
,	NULL
Philadelphia	NULL
,	NULL
PA	NULL
19107-5541	NULL
.	NULL

The	NULL
publication	NULL
costs	NULL
of	NULL
this	NULL
article	NULL
were	NULL
defrayed	NULL
in	NULL
part	NULL
by	NULL
page	NULL
charge	NULL
payment	NULL
.	NULL

This	NULL
article	NULL
must	NULL
therefore	NULL
be	NULL
hereby	NULL
marked	NULL
``	NULL
advertisement	NULL
``	NULL
in	NULL
accordance	NULL
with	NULL
18	NULL
U.S.C	NULL
.	NULL

section	NULL
1734	NULL
solely	NULL
to	NULL
indicate	NULL
this	NULL
fact	NULL
.	NULL

©	NULL
1994	NULL
by	NULL
The	NULL
American	NULL
Society	NULL
of	NULL
Hematology	NULL
.	NULL

0006-497	NULL
1/94/8303-0002	NULL
$	NULL
3.00/0	NULL
651	NULL
From	NULL
www.bloodjournal.org	NULL
by	NULL
guest	NULL
on	NULL
May	NULL
10	NULL
,	NULL
2019	NULL
.	NULL

For	NULL
personal	NULL
use	NULL
only	NULL
.	NULL

652	NULL
tions	NULL
)	NULL
were	NULL
collected	NULL
and	NULL
incubated	NULL
with	NULL
appropriate	NULL
amounts	NULL
of	NULL
an	NULL
anti-T	NULL
,	NULL
-B	NULL
,	NULL
-natural	NULL
killer	NULL
lymphocyte	NULL
,	NULL
-monocyte	NULL
and	NULL
-granulocyte	NULL
monoclonal	NULL
antibody	NULL
(	NULL
MoAb	NULL
)	NULL
cocktail	NULL
as	NULL
described	NULL
``	NULL
supplemented	NULL
with	NULL
three	NULL
other	NULL
MoAb	NULL
(	NULL
anti-CD45	NULL
,	NULL
-CD1	NULL
1a	NULL
,	NULL
-CD71	NULL
,	NULL
Bec-ton	NULL
Dickinson	NULL
,	NULL
Mountain	NULL
View	NULL
,	NULL
CA	NULL
)	NULL
,	NULL
which	NULL
improve	NULL
HPC	NULL
recovery	NULL
and	NULL
purity	NULL
.	NULL
'	NULL

''	NULL
Cells	NULL
were	NULL
then	NULL
incubated	NULL
with	NULL
immunomagnetic	NULL
monodisperse	NULL
microspheres	NULL
coated	NULL
with	NULL
sheep	NULL
antibody	NULL
to	NULL
mouse	NULL
Ig	NULL
(	NULL
Dynabeads	NULL
M450	NULL
,	NULL
Dynal	NULL
,	NULL
Oslo	NULL
,	NULL
Norway	NULL
)	NULL
and	NULL
separated	NULL
with	NULL
a	NULL
magnet	NULL
.	NULL

Clonogenetic	NULL
assay	NULL
.	NULL

-	NULL
Purified	NULL
HPCs	NULL
were	NULL
seeded	NULL
(	NULL
1	NULL
to	NULL
1.5	NULL
X	NULL
10	NULL
cells/mL/dish	NULL
,	NULL
two	NULL
or	NULL
three	NULL
plates	NULL
per	NULL
point	NULL
)	NULL
and	NULL
cultured	NULL
in	NULL
0.9	NULL
%	NULL
methylcellulose	NULL
,	NULL
40	NULL
%	NULL
fetal	NULL
calf	NULL
serum	NULL
(	NULL
FCS	NULL
)	NULL
in	NULL
IMDM	NULL
supplemented	NULL
with	NULL
a-thioglycerol	NULL
(	NULL
10~	NULL
'	NULL
mol/L	NULL
)	NULL
(	NULL
Sigma	NULL
)	NULL
,	NULL
and	NULL
different	NULL
growth	NULL
factors	NULL
as	NULL
detailed	NULL
below	NULL
'	NULL
>	NULL
``	NULL
at	NULL
37°C	NULL
in	NULL
a	NULL
5	NULL
%	NULL
CO	NULL
;	NULL
/5	NULL
%	NULL
O	NULL
;	NULL
,	NULL
/	NULL
90	NULL
%	NULL
N	NULL
;	NULL
,	NULL
humidified	NULL
atmosphere	NULL
.	NULL

In	NULL
nonsupplemented	NULL
FCS	NULL
(	NULL
FCS~	NULL
)	NULL
cultures	NULL
,	NULL
FCS	NULL
was	NULL
substituted	NULL
by	NULL
'	NULL
``	NULL
bovine	NULL
serum	NULL
albumin	NULL
(	NULL
10	NULL
mg/	NULL
mL	NULL
)	NULL
,	NULL
pure	NULL
human	NULL
transferrin	NULL
(	NULL
1	NULL
mg/mL	NULL
)	NULL
,	NULL
human	NULL
low-density	NULL
lipo-proteins	NULL
(	NULL
40	NULL
ug/ml	NULL
)	NULL
,	NULL
insulin	NULL
(	NULL
10	NULL
ug/mL	NULL
)	NULL
,	NULL
sodium	NULL
pyruvate	NULL
(	NULL
10~*	NULL
mol/L	NULL
)	NULL
,	NULL
L-glutamine	NULL
(	NULL
2	NULL
X	NULL
10	NULL
mol/L	NULL
)	NULL
,	NULL
rare	NULL
inorganic	NULL
elements	NULL
'	NULL
supplemented	NULL
with	NULL
iron	NULL
sulphate	NULL
(	NULL
4	NULL
x	NULL
10~®	NULL
mol/L	NULL
)	NULL
,	NULL
and	NULL
nucleosides	NULL
(	NULL
10	NULL
ug/mL	NULL
of	NULL
each	NULL
)	NULL
.	NULL

Both	NULL
FCS*	NULL
and	NULL
FCS~	NULL
cultures	NULL
were	NULL
supplemented	NULL
with	NULL
KL	NULL
(	NULL
10	NULL
ng/mL	NULL
)	NULL
,	NULL
IL-3	NULL
(	NULL
100	NULL
U	NULL
)	NULL
,	NULL
GM-CSF	NULL
(	NULL
10	NULL
ng	NULL
)	NULL
,	NULL
and	NULL
Ep	NULL
(	NULL
3	NULL
U	NULL
)	NULL
.	NULL

RA	NULL
(	NULL
Sigma	NULL
)	NULL
was	NULL
added	NULL
either	NULL
on	NULL
day	NULL
0	NULL
only	NULL
or	NULL
every	NULL
2	NULL
to	NULL
3	NULL
days	NULL
.	NULL

CFU-granulocyte	NULL
,	NULL
erythroid	NULL
,	NULL
monocyte	NULL
,	NULL
megakaryocyte	NULL
(	NULL
GEMM	NULL
)	NULL
,	NULL
burst-forming	NULL
unit	NULL
erythroid	NULL
(	NULL
BFU-E	NULL
)	NULL
,	NULL
and	NULL
CFU-GM	NULL
colonies	NULL
were	NULL
scored	NULL
on	NULL
day	NULL
14	NULL
or	NULL
16	NULL
through	NULL
18	NULL
in	NULL
FCS*	NULL
or	NULL
FCS~	NULL
culture	NULL
,	NULL
respectively	NULL
.	NULL

In	NULL
selected	NULL
experiments	NULL
,	NULL
colonies	NULL
were	NULL
picked	NULL
up	NULL
and	NULL
the	NULL
cell	NULL
composition	NULL
analyzed	NULL
as	NULL
described	NULL
.	NULL
``	NULL

Liquid	NULL
suspension	NULL
culture	NULL
.	NULL

-	NULL
Step	NULL
HIP	NULL
HPs	NULL
grown	NULL
in	NULL
FCS	NULL
liquid	NULL
culture	NULL
(	NULL
1	NULL
to	NULL
5	NULL
X	NULL
10°	NULL
cells/mL	NULL
in	NULL
IMDM	NULL
,	NULL
supplemented	NULL
as	NULL
indicated	NULL
above	NULL
)	NULL
were	NULL
induced	NULL
to	NULL
specific	NULL
erythroid	NULL
or	NULL
granulocytic	NULL
differentiation	NULL
by	NULL
appropriate	NULL
th	NULL
hematopoietic	NULL
growth-factor	NULL
combinations	NULL
detailed	NULL
below	NULL
``	NULL
in	NULL
a	NULL
fully	NULL
humidified	NULL
5	NULL
%	NULL
CO	NULL
;	NULL
/5	NULL
%	NULL
0	NULL
;	NULL
/90	NULL
%	NULL
N	NULL
;	NULL
atmosphere	NULL
.	NULL

RA	NULL
was	NULL
added	NULL
on	NULL
day	NULL
0	NULL
and	NULL
refed	NULL
in	NULL
fresh	NULL
medium	NULL
every	NULL
3	NULL
to	NULL
4	NULL
days	NULL
.	NULL

Morphology	NULL
analysis	NULL
.	NULL

Cells	NULL
were	NULL
harvested	NULL
at	NULL
different	NULL
days	NULL
,	NULL
smeared	NULL
on	NULL
glass	NULL
slides	NULL
by	NULL
cytospin	NULL
centrifugation	NULL
,	NULL
and	NULL
stained	NULL
with	NULL
May-Griinwald	NULL
Giemsa	NULL
.	NULL

Reverse	NULL
transcriptase-polymerase	NULL
chain	NULL
reaction	NULL
(	NULL
RT-PCR	NULL
)	NULL
analysis	NULL
.	NULL

Total	NULL
RNA	NULL
,	NULL
extracted	NULL
by	NULL
the	NULL
guanidinium	NULL
isothiocyanate/	NULL
CsCl	NULL
method	NULL
``	NULL
``	NULL
from	NULL
the	NULL
same	NULL
number	NULL
of	NULL
cells	NULL
in	NULL
the	NULL
presence	NULL
of	NULL
12	NULL
ug	NULL
of	NULL
Escherichia	NULL
coli	NULL
tRNA	NULL
,	NULL
was	NULL
quantitated	NULL
by	NULL
dot	NULL
hybridization	NULL
with	NULL
a	NULL
human	NULL
rRNA	NULL
probe	NULL
.	NULL
``	NULL

After	NULL
densitometric	NULL
analysis	NULL
,	NULL
the	NULL
normalized	NULL
amount	NULL
of	NULL
RNA	NULL
was	NULL
reverse-transcribed	NULL
(	NULL
Moloney	NULL
murine	NULL
leukemia	NULL
virus	NULL
RT	NULL
,	NULL
BRL	NULL
)	NULL
with	NULL
oligo	NULL
(	NULL
dT	NULL
)	NULL
as	NULL
primer	NULL
.	NULL

After	NULL
82	NULL
micro-globulin	NULL
normalization	NULL
,	NULL
``	NULL
amplification	NULL
within	NULL
the	NULL
linear	NULL
range	NULL
was	NULL
achieved	NULL
by	NULL
20	NULL
cycles	NULL
of	NULL
PCR	NULL
consisting	NULL
of	NULL
denaturation	NULL
at	NULL
95°C	NULL
for	NULL
1.5	NULL
minutes	NULL
,	NULL
annealing	NULL
at	NULL
52°C	NULL
for	NULL
1.5	NULL
minutes	NULL
,	NULL
and	NULL
extension	NULL
at	NULL
72°C	NULL
for	NULL
1.5	NULL
minutes	NULL
.	NULL

Primers	NULL
for	NULL
GATAZ	NULL
were	NULL
5-TTAGCCACC-TCATGCCTT-3	NULL
and	NULL
S-ACATCGGTCTTAAGACCT-3*	NULL
and	NULL
generated	NULL
a	NULL
PCR	NULL
product	NULL
of	NULL
194	NULL
bp	NULL
.	NULL

PCR	NULL
was	NULL
performed	NULL
in	NULL
a	NULL
total	NULL
volume	NULL
of	NULL
100	NULL
LL	NULL
,	NULL
and	NULL
10	NULL
gL	NULL
of	NULL
each	NULL
sample	NULL
were	NULL
electrophoresed	NULL
in	NULL
a	NULL
2	NULL
%	NULL
agarose	NULL
gel	NULL
and	NULL
transferred	NULL
to	NULL
a	NULL
nylon	NULL
filter	NULL
for	NULL
hybridization	NULL
with	NULL
an	NULL
internal	NULL
40-mer	NULL
GATA	NULL
!	NULL

probe	NULL
(	NULL
5-TACTGTGGTGGC-TCCGCTCAGCTCATGAGGCACAGAG	NULL
CA-3	NULL
``	NULL
)	NULL
.	NULL

In	NULL
control	NULL
experiments	NULL
,	NULL
serial	NULL
dilutions	NULL
of	NULL
samples	NULL
were	NULL
amplified	NULL
;	NULL
the	NULL
dose-response	NULL
curves	NULL
showed	NULL
linearity	NULL
for	NULL
all	NULL
points	NULL
.	NULL

Relative	NULL
intensities	NULL
of	NULL
bands	NULL
were	NULL
quantified	NULL
by	NULL
scanning	NULL
with	NULL
a	NULL
laser	NULL
densitometer	NULL
(	NULL
LKB	NULL
)	NULL
.	NULL

RESULTS	NULL
Stringently	NULL
purified	NULL
(	NULL
Step	NULL
IIP	NULL
)	NULL
adult	NULL
PB	NULL
HPs	NULL
seeded	NULL
in	NULL
FCS*	NULL
clonogenetic	NULL
culture	NULL
in	NULL
presence	NULL
of	NULL
saturating	NULL
doses	NULL
of	NULL
KL/IL-3/GM-CSF/Ep	NULL
give	NULL
rise	NULL
to	NULL
a	NULL
majority	NULL
of	NULL
BFU-E	NULL
{	NULL
comprising	NULL
few	NULL
CFU-GEMM	NULL
)	NULL
clones	NULL
and	NULL
a	NULL
minority	NULL
of	NULL
CFU-GM	NULL
colonies	NULL
(	NULL
the	NULL
latter	NULL
were	NULL
largely	NULL
composed	NULL
of	NULL
G	NULL
LABBAYE	NULL
ET	NULL
AL	NULL
Colony	NULL
number	NULL
/	NULL
100	NULL
cells	NULL
o	NULL
8	NULL
&	NULL
$	NULL
3	NULL
i_	NULL
1	NULL
___	NULL
_	NULL
.	NULL

B	NULL
100	NULL
a	NULL
g	NULL
80	NULL
o	NULL
o	NULL
2	NULL
-	NULL
605	NULL
pri	NULL
E	NULL
E	NULL
2	NULL
401	NULL
>	NULL
C	NULL
2	NULL
8	NULL
201	NULL
y	NULL
o	NULL
_	NULL
KL	NULL
/	NULL
IL-3	NULL
/	NULL
GM-CSF	NULL
/	NULL
Ep	NULL
Fig	NULL
1	NULL
.	NULL

Effect	NULL
of	NULL
RA	NULL
addition	NULL
on	NULL
BFU-E	NULL
(	NULL
comprising	NULL
a	NULL
minority	NULL
of	NULL
CFU-GEMM	NULL
)	NULL
,	NULL
CFU-GM	NULL
and	NULL
total	NULL
colony	NULL
formation	NULL
by	NULL
adult	NULL
PB	NULL
purified	NULL
(	NULL
Step	NULL
IIP	NULL
}	NULL
HPCs	NULL
in	NULL
FCS	NULL
*	NULL
{	NULL
A	NULL
}	NULL
or	NULL
FCS	NULL
~	NULL
(	NULL
B	NULL
}	NULL
semisolid	NULL
culture	NULL
supplemented	NULL
with	NULL
KL	NULL
(	NULL
10	NULL
ng/ml	NULL
}	NULL
,	NULL
IL-3	NULL
(	NULL
100	NULL
U	NULL
)	NULL
,	NULL
GM-CSF	NULL
(	NULL
10	NULL
ng	NULL
)	NULL
,	NULL
and	NULL
Ep	NULL
(	NULL
3	NULL
U	NULL
)	NULL
.	NULL

(	NULL
A	NULL
)	NULL
Mean	NULL
+	NULL
SEM	NULL
values	NULL
from	NULL
three	NULL
separate	NULL
experiments	NULL
.	NULL

{	NULL
B	NULL
)	NULL
Mean	NULL
+	NULL
SEM	NULL
values	NULL
derived	NULL
from	NULL
a	NULL
single	NULL
experiment	NULL
plated	NULL
in	NULL
triplicate	NULL
.	NULL

P	NULL
<	NULL
.01	NULL
when	NULL
comparing	NULL
BFU-E	NULL
and	NULL
CFU-GM	NULL
colony	NULL
number	NULL
in	NULL
RA~	NULL
versus	NULL
RA	NULL
*	NULL
culture	NULL
.	NULL

precursors/terminal	NULL
cells	NULL
,	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
:	NULL
addition	NULL
of	NULL
peak	NULL
RA	NULL
dosage	NULL
(	NULL
107°	NULL
mol/L	NULL
)	NULL
causes	NULL
a	NULL
drastic	NULL
decrease	NULL
of	NULL
the	NULL
erythroid	NULL
colonies	NULL
,	NULL
and	NULL
an	NULL
inverse	NULL
rise	NULL
of	NULL
the	NULL
granulocytic	NULL
clones	NULL
(	NULL
Fig	NULL
1	NULL
A	NULL
and	NULL
B	NULL
)	NULL
.	NULL

In	NULL
these	NULL
studies	NULL
,	NULL
the	NULL
total	NULL
number	NULL
of	NULL
colonies	NULL
is	NULL
not	NULL
significantly	NULL
modified	NULL
by	NULL
RA	NULL
addition	NULL
.	NULL

The	NULL
lack	NULL
of	NULL
change	NULL
of	NULL
total	NULL
number	NULL
,	NULL
particularly	NULL
in	NULL
experiments	NULL
with	NULL
greater	NULL
than	NULL
90	NULL
%	NULL
purified	NULL
HPs	NULL
(	NULL
Fig	NULL
1B	NULL
)	NULL
,	NULL
indicates	NULL
that	NULL
the	NULL
erythroid	NULL
to	NULL
granulocytic	NULL
clonogenetic	NULL
shift	NULL
is	NULL
not	NULL
mediated	NULL
by	NULL
recruitment	NULL
of	NULL
HPCs	NULL
.	NULL

A	NULL
detailed	NULL
analysis	NULL
of	NULL
these	NULL
phenomena	NULL
in	NULL
FCS*	NULL
or	NULL
FCS~	NULL
clonogenetic	NULL
purified	NULL
HPC	NULL
culture	NULL
shows	NULL
that	NULL
the	NULL
RA	NULL
effect	NULL
is	NULL
dose-dependent	NULL
(	NULL
Fig	NULL
2A	NULL
)	NULL
.	NULL

The	NULL
sensitivity	NULL
of	NULL
HPCs	NULL
to	NULL
RA	NULL
treatment	NULL
is	NULL
more	NULL
pronounced	NULL
in	NULL
FCS~	NULL
than	NULL
FCS*	NULL
culture	NULL
conditions	NULL
,	NULL
ie	NULL
,	NULL
a	NULL
marked	NULL
effect	NULL
is	NULL
respectively	NULL
observed	NULL
at	NULL
107°	NULL
and	NULL
10~°	NULL
mol/L	NULL
concentration	NULL
.	NULL

The	NULL
more	NULL
pronounced	NULL
sensitivity	NULL
of	NULL
HPCs	NULL
to	NULL
RA	NULL
in	NULL
FCS~	NULL
versus	NULL
FCS*	NULL
culture	NULL
may	NULL
be	NULL
attributed	NULL
to	NULL
retinol-binding	NULL
protein	NULL
in	NULL
serum	NULL
.	NULL
``	NULL

In	NULL
this	NULL
regard	NULL
,	NULL
a	NULL
3	NULL
X	NULL
10~	NULL
concentration	NULL
is	NULL
monitored	NULL
in	NULL
normal	NULL
human	NULL
peripheral	NULL
plasma	NULL
,	NULL
``	NULL
``	NULL
and	NULL
a	NULL
10~®	NULL
to	NULL
10~	NULL
'	NULL
concentration	NULL
is	NULL
present	NULL
in	NULL
chicken	NULL
wingbud	NULL
RA	NULL
gradients	NULL
.	NULL
``	NULL

The	NULL
RA	NULL
concentration	NULL
and	NULL
possible	NULL
gradients	NULL
in	NULL
normal	NULL
BM	NULL
have	NULL
not	NULL
yet	NULL
been	NULL
verified	NULL
.	NULL

In	NULL
time-response	NULL
experiments	NULL
the	NULL
RA	NULL
action	NULL
gradually	NULL
From	NULL
www.bloodjournal.org	NULL
by	NULL
guest	NULL
on	NULL
May	NULL
10	NULL
,	NULL
2019	NULL
.	NULL

For	NULL
personal	NULL
use	NULL
only	NULL
.	NULL

RETINOIC	NULL
ACID	NULL
INHIBITION	NULL
OF	NULL
ERYTHROPOIESIS	NULL
decreases	NULL
as	NULL
treatment	NULL
is	NULL
progressively	NULL
delayed	NULL
,	NULL
down	NULL
to	NULL
absence	NULL
of	NULL
significant	NULL
effects	NULL
when	NULL
RA	NULL
is	NULL
added	NULL
at	NULL
day	NULL
6	NULL
through	NULL
8	NULL
(	NULL
Fig	NULL
2B	NULL
)	NULL
.	NULL

This	NULL
indicates	NULL
that	NULL
the	NULL
RA	NULL
action	NULL
takes	NULL
place	NULL
mainly	NULL
at	NULL
the	NULL
level	NULL
of	NULL
early	NULL
HPCs	NULL
(	NULL
day	NULL
0	NULL
through	NULL
2	NULL
in	NULL
culture	NULL
)	NULL
,	NULL
gradually	NULL
decreases	NULL
when	NULL
RA	NULL
is	NULL
added	NULL
onto	NULL
intermediate	NULL
HPCs	NULL
(	NULL
day	NULL
4	NULL
through	NULL
6	NULL
of	NULL
culture	NULL
)	NULL
,	NULL
and	NULL
has	NULL
no	NULL
effect	NULL
on	NULL
late	NULL
HPCs	NULL
or	NULL
early	NULL
erythroid	NULL
precursors	NULL
(	NULL
day	NULL
8	NULL
of	NULL
culture	NULL
)	NULL
.	NULL

To	NULL
further	NULL
evaluate	NULL
the	NULL
RA	NULL
effect	NULL
,	NULL
studies	NULL
were	NULL
performed	NULL
FCS*	NULL
CULTURE	NULL
MEX	NULL
=|	NULL
+	NULL
CFU-GM	NULL
BFU-E	NULL
g	NULL
0	NULL
o	NULL
10	NULL
*	NULL
10	NULL
%	NULL
10	NULL
7	NULL
to	NULL
*	NULL
M	NULL
Repeated	NULL
RA	NULL
addition	NULL
so	NULL
&	NULL
E	NULL
8	NULL
Colony	NULL
number	NULL
/	NULL
150	NULL
cells	NULL
®	NULL
Single	NULL
RA	NULL
(	NULL
10	NULL
M	NULL
)	NULL
addition	NULL
KL	NULL
/	NULL
IL-3	NULL
/	NULL
GM-CSF	NULL
/	NULL
Ep	NULL
FCS	NULL
:	NULL
CULTURE	NULL
TOTAL	NULL
{	NULL
g	NULL
o	NULL
0	NULL
10	NULL
#	NULL
10	NULL
*	NULL
10	NULL
``	NULL
10	NULL
*	NULL
M	NULL
Single	NULL
RA	NULL
(	NULL
10	NULL
``	NULL
M	NULL
)	NULL
addition	NULL
RA	NULL
IL-3	NULL
/	NULL
GM-CSF	NULL
/	NULL
Ep	NULL
KL	NULL
/	NULL
IL-3	NULL
/	NULL
GM-CSF	NULL
/	NULL
Ep	NULL
TOTAL	NULL
80	NULL
BFU-E	NULL
60	NULL
40	NULL
CFU-GM	NULL
20	NULL
0	NULL
0	NULL
1	NULL
2	NULL
5	NULL
Day	NULL
of	NULL
RA	NULL
(	NULL
10	NULL
°M	NULL
)	NULL
addition	NULL
RA~	NULL
Colony	NULL
number	NULL
/	NULL
100	NULL
cells	NULL
Fig	NULL
2	NULL
.	NULL

RA	NULL
dose-response	NULL
(	NULL
A	NULL
)	NULL
and	NULL
delayed	NULL
RA	NULL
(	NULL
10~®	NULL
mol/L	NULL
)	NULL
addition	NULL
(	NULL
B	NULL
)	NULL
effects	NULL
on	NULL
BFU-E	NULL
(	NULL
comprising	NULL
a	NULL
minority	NULL
of	NULL
CFU-GEMM	NULL
}	NULL
,	NULL
CFU-GM	NULL
,	NULL
and	NULL
total	NULL
colony	NULL
formation	NULL
by	NULL
PB	NULL
Step	NULL
I	NULL
{	NULL
IP	NULL
purified	NULL
HPCs	NULL
(	NULL
in	NULL
[	NULL
A	NULL
]	NULL
,	NULL
cultures	NULL
were	NULL
performed	NULL
in	NULL
FCS	NULL
*	NULL
[	NULL
top	NULL
]	NULL
or	NULL
FCS~	NULL
[	NULL
bottom	NULL
]	NULL
medium	NULL
)	NULL
.	NULL

RA	NULL
was	NULL
added	NULL
every	NULL
2	NULL
to	NULL
3	NULL
days	NULL
where	NULL
indicated	NULL
.	NULL

Single	NULL
RA	NULL
addition	NULL
was	NULL
on	NULL
day	NULL
0	NULL
.	NULL

Mean	NULL
+	NULL
SEM	NULL
values	NULL
from	NULL
either	NULL
triplicate	NULL
dishes	NULL
in	NULL
a	NULL
representative	NULL
experiment	NULL
(	NULL
A	NULL
,	NULL
top	NULL
,	NULL
and	NULL
B	NULL
)	NULL
or	NULL
four	NULL
separate	NULL
experiments	NULL
(	NULL
A	NULL
,	NULL
bottom	NULL
)	NULL
.	NULL

(	NULL
A	NULL
,	NULL
top	NULL
)	NULL
P	NULL
<	NULL
.04	NULL
or	NULL
.02	NULL
when	NULL
comparing	NULL
BFU-E	NULL
or	NULL
CFU-GM	NULL
colony	NULL
number	NULL
,	NULL
respectively	NULL
,	NULL
between	NULL
RA~	NULL
and	NULL
RA	NULL
*	NULL
(	NULL
10~®	NULL
mol/L	NULL
)	NULL
groups	NULL
.	NULL

(	NULL
A	NULL
,	NULL
bottom	NULL
left	NULL
)	NULL
P	NULL
<	NULL
.01	NULL
when	NULL
comparing	NULL
BFU-E	NULL
and	NULL
CFU-GM	NULL
colony	NULL
number	NULL
between	NULL
RA~	NULL
and	NULL
RA	NULL
*	NULL
groups	NULL
at	NULL
10	NULL
~®	NULL
,	NULL
10	NULL
~	NULL
``	NULL
,	NULL
and	NULL
10~®	NULL
mol/L	NULL
RA	NULL
dosages	NULL
.	NULL

(	NULL
@	NULL
)	NULL
Total	NULL
colonies	NULL
,	NULL
(	NULL
a	NULL
)	NULL
BFU-E	NULL
colonies	NULL
;	NULL
(	NULL
C	NULL
)	NULL
CFU-GM	NULL
colonies	NULL
.	NULL

653	NULL
A	NULL
-o-	NULL
Ep	NULL
(	NULL
3	NULL
Uimi	NULL
)	NULL
+	NULL
IL-3	NULL
(	NULL
0.01	NULL
U	NULL
)	NULL
+	NULL
GM-CSF	NULL
(	NULL
0.001	NULL
ng	NULL
)	NULL
-*-	NULL
Ep	NULL
o	NULL
``	NULL
+	NULL
+0	NULL
%	NULL
+Raqto®	NULL
M	NULL
)	NULL
-a-	NULL
IL-3	NULL
(	NULL
100	NULL
U	NULL
)	NULL
a	NULL
GM-CSF	NULL
(	NULL
10	NULL
ng	NULL
)	NULL
-a-	NULL
+0005	NULL
+RA	NULL
(	NULL
10	NULL
*M	NULL
)	NULL
10	NULL
*	NULL
&	NULL
10	NULL
®	NULL
€	NULL
3	NULL
2	NULL
8	NULL
E	NULL
s	NULL
$	NULL
0	NULL
2	NULL
10	NULL
+	NULL
0	NULL
5	NULL
10	NULL
15	NULL
Days	NULL
®	NULL
BAso	NULL
.	NULL

ERVT	NULL
.	NULL

B	NULL
m	NULL
I	NULL
ontHo	NULL
.	NULL

Day	NULL
12	NULL
F	NULL
)	NULL
IMMATURE	NULL
MYELOID	NULL
NEUTROPHILS	NULL
100	NULL
[	NULL
EosiNoPHILS	NULL
so	NULL
a	NULL
so	NULL
©	NULL
0	NULL
®	NULL
-	NULL
ao	NULL
20	NULL
o	NULL
-	NULL
+	NULL
-	NULL
4	NULL
_	NULL
Ra	NULL
(	NULL
10	NULL
M	NULL
)	NULL
hey	NULL
l/	NULL
IL-3	NULL
(	NULL
0.01	NULL
U	NULL
)	NULL
+	NULL
GM-CSF	NULL
(	NULL
0.001	NULL
ng	NULL
)	NULL
+	NULL
Ep	NULL
(	NULL
3	NULL
Umi	NULL
)	NULL
R/	NULL
IL-3	NULL
(	NULL
100	NULL
U	NULL
)	NULL
+	NULL
GM-CSF	NULL
(	NULL
10	NULL
ng	NULL
)	NULL
Fig	NULL
3	NULL
.	NULL

Effects	NULL
of	NULL
RA	NULL
addition	NULL
on	NULL
cell	NULL
proliferation	NULL
(	NULL
A	NULL
)	NULL
and	NULL
differentiation	NULL
(	NULL
B	NULL
)	NULL
of	NULL
PB	NULL
Step	NULL
IIIP-purified	NULL
HPCs	NULL
in	NULL
FCS~	NULL
liquid	NULL
culture	NULL
specific	NULL
for	NULL
erythroid	NULL
(	NULL
saturating	NULL
Ep	NULL
+	NULL
subliminal	NULL
IL-3	NULL
and	NULL
GM-CSF	NULL
dosages	NULL
)	NULL
or	NULL
granulocytic	NULL
(	NULL
saturating	NULL
IL-3	NULL
and	NULL
GM-CSF	NULL
doses	NULL
)	NULL
differentiation	NULL
.	NULL

Mean	NULL
+	NULL
SEM	NULL
from	NULL
four	NULL
separate	NULL
experiments	NULL
.	NULL

(	NULL
A	NULL
)	NULL
P	NULL
<	NULL
.05	NULL
or	NULL
.01	NULL
when	NULL
comparing	NULL
RA	NULL
*	NULL
versus	NULL
RA~	NULL
group	NULL
in	NULL
the	NULL
erythroid	NULL
differentiation	NULL
culture	NULL
at	NULL
day	NULL
9	NULL
or	NULL
12	NULL
and	NULL
14	NULL
,	NULL
respectively	NULL
.	NULL

in	NULL
liquid-phase	NULL
FCS~	NULL
culture	NULL
of	NULL
purified	NULL
Step	NULL
IIIP	NULL
HPs	NULL
differentiating	NULL
specifically	NULL
along	NULL
the	NULL
erythroid	NULL
or	NULL
granulocytic	NULL
lineage	NULL
,	NULL
upon	NULL
addition	NULL
of	NULL
either	NULL
low-dose	NULL
IL-3/GM-CSF	NULL
combined	NULL
with	NULL
saturating	NULL
Ep	NULL
dosage	NULL
or	NULL
high-dose	NULL
IL-3/GM-CSF	NULL
,	NULL
respectively	NULL
.	NULL
``	NULL

In	NULL
the	NULL
erythropoietic	NULL
system	NULL
,	NULL
cell	NULL
growth	NULL
is	NULL
markedly	NULL
inhibited	NULL
by	NULL
RA	NULL
,	NULL
together	NULL
with	NULL
a	NULL
drastic	NULL
shift	NULL
from	NULL
the	NULL
erythroid	NULL
to	NULL
granulocytic	NULL
lineage	NULL
,	NULL
mainly	NULL
of	NULL
neutrophilic	NULL
type	NULL
(	NULL
Fig	NULL
3A	NULL
)	NULL
.	NULL

Conversely	NULL
,	NULL
in	NULL
the	NULL
G-specific	NULL
culture	NULL
system	NULL
,	NULL
cell	NULL
proliferation	NULL
and	NULL
differentiation	NULL
are	NULL
essentially	NULL
unaffected	NULL
by	NULL
RA	NULL
(	NULL
Fig	NULL
3B	NULL
)	NULL
.	NULL

Finally	NULL
,	NULL
HPCs	NULL
grown	NULL
in	NULL
the	NULL
erythroid	NULL
liquid-culture	NULL
system	NULL
were	NULL
exposed	NULL
to	NULL
a	NULL
``	NULL
pulse	NULL
``	NULL
RA	NULL
stimulus	NULL
for	NULL
6	NULL
,	NULL
24	NULL
,	NULL
or	NULL
96	NULL
hours	NULL
.	NULL

The	NULL
duration	NULL
of	NULL
RA	NULL
treatment	NULL
was	NULL
directly	NULL
related	NULL
to	NULL
the	NULL
inhibitory	NULL
effect	NULL
on	NULL
cell	NULL
growth	NULL
(	NULL
Fig	NULL
4A	NULL
)	NULL
,	NULL
as	NULL
well	NULL
as	NULL
to	NULL
the	NULL
retardation	NULL
of	NULL
erythroid	NULL
differentiation	NULL
(	NULL
Fig	NULL
4B	NULL
)	NULL
.	NULL

Interestingly	NULL
a	NULL
6-hour	NULL
pulse	NULL
was	NULL
sufficient	NULL
to	NULL
moderately	NULL
affect	NULL
both	NULL
parameters	NULL
.	NULL

In	NULL
an	NULL
attempt	NULL
to	NULL
define	NULL
the	NULL
molecular	NULL
mechanism	NULL
underlying	NULL
the	NULL
erythroid	NULL
to	NULL
granulocytic	NULL
differentiation	NULL
shift	NULL
elicited	NULL
by	NULL
RA	NULL
in	NULL
HPC	NULL
culture	NULL
,	NULL
we	NULL
have	NULL
analyzed	NULL
GATA	NULL
]	NULL
mRNA	NULL
expression	NULL
in	NULL
HPCs	NULL
differentiating	NULL
in	NULL
the	NULL
unilineage	NULL
erythroid	NULL
or	NULL
granulocytic	NULL
liquid-suspension	NULL
culture	NULL
From	NULL
www.bloodjournal.org	NULL
by	NULL
guest	NULL
on	NULL
May	NULL
10	NULL
,	NULL
2019	NULL
.	NULL

For	NULL
personal	NULL
use	NULL
only	NULL
.	NULL

654	NULL
-o-	NULL
Control	NULL
-e-	NULL
RA	NULL
(	NULL
10	NULL
*	NULL
M	NULL
)	NULL
-a-	NULL
RA	NULL
6-h	NULL
Pulse	NULL
10	NULL
-a-	NULL
``	NULL
24-h	NULL
Pulse	NULL
-	NULL
«	NULL
-	NULL
_	NULL
``	NULL
96-h	NULL
Pulse	NULL
Total	NULL
Cell	NULL
Number	NULL
Days	NULL
B	NULL
m	NULL
BAso	NULL
.	NULL

ERYT	NULL
.	NULL

POLY	NULL
.	NULL

Day	NULL
16	NULL
{	NULL
®	NULL
ORTHO	NULL
.	NULL

100	NULL
-	NULL
\	NULL
(	NULL
3	NULL
NEUTROPHILS	NULL
~	NULL
C	NULL
)	NULL
EOSINOPHILS	NULL
Control	NULL
0	NULL
-	NULL
>	NULL
6	NULL
h	NULL
RA	NULL
(	NULL
10	NULL
%	NULL
M	NULL
)	NULL
_.	NULL
ﬁfﬁ/	NULL
RA	NULL
(	NULL
10	NULL
®	NULL
M	NULL
)	NULL
Pulse	NULL
0	NULL
-	NULL
>	NULL
24	NULL
h	NULL
0	NULL
-	NULL
>	NULL
96	NULL
h	NULL
Fig	NULL
4	NULL
.	NULL

Effect	NULL
of	NULL
RA	NULL
pulse	NULL
treatment	NULL
on	NULL
proliferation	NULL
(	NULL
A	NULL
)	NULL
and	NULL
differentiation	NULL
(	NULL
B	NULL
)	NULL
of	NULL
Step	NULL
IIIP-purified	NULL
adult	NULL
HPCs	NULL
in	NULL
FCS~	NULL
liquid	NULL
culture	NULL
specific	NULL
for	NULL
erythroid	NULL
differentiation	NULL
.	NULL

A	NULL
representative	NULL
experiment	NULL
is	NULL
shown	NULL
.	NULL

system	NULL
supplemented	NULL
or	NULL
not	NULL
with	NULL
RA	NULL
(	NULL
Fig	NULL
5	NULL
)	NULL
.	NULL

In	NULL
absence	NULL
of	NULL
RA	NULL
we	NULL
observed	NULL
,	NULL
in	NULL
line	NULL
with	NULL
our	NULL
previous	NULL
studies	NULL
,	NULL
``	NULL
``	NULL
that	NULL
(	NULL
1	NULL
)	NULL
the	NULL
GATA	NULL
I	NULL
gene	NULL
is	NULL
barely	NULL
expressed	NULL
in	NULL
the	NULL
initial	NULL
population	NULL
of	NULL
quiescent	NULL
HPCs	NULL
;	NULL
(	NULL
2	NULL
)	NULL
in	NULL
the	NULL
E	NULL
differentiation	NULL
pathway	NULL
,	NULL
GATALI	NULL
expression	NULL
is	NULL
induced	NULL
and	NULL
then	NULL
gradually	NULL
enhanced	NULL
through	NULL
the	NULL
initial	NULL
stages	NULL
of	NULL
maturation	NULL
;	NULL
and	NULL
(	NULL
3	NULL
)	NULL
differentiation	NULL
along	NULL
the	NULL
granulocytic	NULL
pathway	NULL
is	NULL
initially	NULL
associated	NULL
with	NULL
induction	NULL
of	NULL
GAT	NULL
AI	NULL
expression	NULL
,	NULL
which	NULL
is	NULL
then	NULL
downmodulated	NULL
at	NULL
the	NULL
level	NULL
of	NULL
late	NULL
progenitors/early	NULL
differentiated	NULL
precursors	NULL
(	NULL
day	NULL
5	NULL
through	NULL
9	NULL
of	NULL
culture	NULL
)	NULL
(	NULL
Fig	NULL
5	NULL
)	NULL
.	NULL

RA	NULL
addition	NULL
to	NULL
HPC	NULL
differentiating	NULL
in	NULL
the	NULL
erythroid	NULL
culture	NULL
system	NULL
caused	NULL
a	NULL
drastic	NULL
inhibition	NULL
of	NULL
GATAZL	NULL
mRNA	NULL
induction	NULL
;	NULL
in	NULL
contrast	NULL
,	NULL
addition	NULL
of	NULL
RA	NULL
in	NULL
the	NULL
granulocytic	NULL
differentiation	NULL
culture	NULL
did	NULL
not	NULL
modify	NULL
the	NULL
pattern	NULL
of	NULL
GATAL	NULL
expression	NULL
,	NULL
except	NULL
possibly	NULL
for	NULL
a	NULL
moderate	NULL
decline	NULL
at	NULL
day	NULL
5	NULL
(	NULL
Fig	NULL
5	NULL
)	NULL
.	NULL

Thus	NULL
,	NULL
in	NULL
the	NULL
first	NULL
week	NULL
of	NULL
erythroid	NULL
culture	NULL
,	NULL
RA	NULL
treatment	NULL
causes	NULL
both	NULL
a	NULL
marked	NULL
inhibitory	NULL
effect	NULL
on	NULL
erythropoietic	NULL
differentiation	NULL
and	NULL
a	NULL
complete	NULL
suppression	NULL
of	NULL
GATAL	NULL
induction	NULL
.	NULL

DISCUSSION	NULL
All-trans	NULL
RA	NULL
is	NULL
a	NULL
high-affinity	NULL
ligand	NULL
of	NULL
RA	NULL
receptors	NULL
``	NULL
*	NULL
and	NULL
a	NULL
physiologic	NULL
constituent	NULL
in	NULL
human	NULL
blood	NULL
.	NULL
``	NULL

''	NULL
Our	NULL
studies	NULL
indicate	NULL
that	NULL
RA	NULL
induces	NULL
a	NULL
dose-dependent	NULL
shift	NULL
of	NULL
highly	NULL
purified	NULL
adult	NULL
HP	NULL
from	NULL
the	NULL
erythrocytic	NULL
to	NULL
LABBAYE	NULL
ET	NULL
AL	NULL
granulocytic	NULL
differentiation	NULL
pathway	NULL
.	NULL

Similar	NULL
results	NULL
have	NULL
been	NULL
obtained	NULL
with	NULL
purified	NULL
embryonic-fetal	NULL
liver	NULL
HPCs	NULL
(	NULL
not	NULL
shown	NULL
here	NULL
)	NULL
.	NULL

Interestingly	NULL
,	NULL
the	NULL
biologic	NULL
effects	NULL
of	NULL
RA	NULL
are	NULL
not	NULL
shared	NULL
by	NULL
other	NULL
members	NULL
of	NULL
the	NULL
steroid-	NULL
and	NULL
thyroid-hormone	NULL
ligand	NULL
superfamily	NULL
``	NULL
®	NULL
including	NULL
thyroxine	NULL
,	NULL
gluco-corticoids	NULL
,	NULL
testosterone	NULL
,	NULL
B-estradiol	NULL
,	NULL
and	NULL
progesterone	NULL
(	NULL
U.	NULL
Testa	NULL
,	NULL
C.	NULL
Peschle	NULL
,	NULL
unpublished	NULL
data	NULL
,	NULL
June	NULL
1993	NULL
)	NULL
.	NULL

The	NULL
stringent	NULL
purification	NULL
of	NULL
adult	NULL
HPCs	NULL
and	NULL
the	NULL
low	NULL
number	NULL
of	NULL
cells	NULL
seeded	NULL
in	NULL
clonogenetic	NULL
culture	NULL
render	NULL
unlikely	NULL
the	NULL
possibility	NULL
of	NULL
an	NULL
indirect	NULL
RA	NULL
effect	NULL
via	NULL
the	NULL
coplated	NULL
accessory	NULL
cells	NULL
(	NULL
eg	NULL
,	NULL
<	NULL
10	NULL
accessory	NULL
cells/mL	NULL
were	NULL
present	NULL
in	NULL
the	NULL
cultures	NULL
shown	NULL
in	NULL
Fig	NULL
1B	NULL
)	NULL
.	NULL

Furthermore	NULL
,	NULL
the	NULL
RA	NULL
effects	NULL
have	NULL
been	NULL
confirmed	NULL
in	NULL
unicellular	NULL
Step	NULL
IIP	NULL
purified	NULL
HPCs	NULL
(	NULL
results	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

The	NULL
RA	NULL
effect	NULL
has	NULL
been	NULL
observed	NULL
in	NULL
both	NULL
FCS*	NULL
and	NULL
FCS~	NULL
clonogenetic	NULL
or	NULL
liquid	NULL
suspension	NULL
cultures	NULL
and	NULL
in	NULL
presence	NULL
of	NULL
different	NULL
growth-factors	NULL
stimuli	NULL
inducing	NULL
either	NULL
multilineage	NULL
(	NULL
erythropoietic	NULL
and	NULL
granulopoietic	NULL
)	NULL
or	NULL
unilineage	NULL
(	NULL
erythrocytic	NULL
or	NULL
granulocytic	NULL
)	NULL
differentiation	NULL
.	NULL

It	NULL
follows	NULL
that	NULL
the	NULL
action	NULL
exerted	NULL
by	NULL
RA	NULL
directly	NULL
on	NULL
HPCs	NULL
is	NULL
independent	NULL
from	NULL
the	NULL
culture	NULL
conditions	NULL
,	NULL
including	NULL
the	NULL
type	NULL
of	NULL
erythropoietic	NULL
growth-factor	NULL
stimulus	NULL
.	NULL

It	NULL
is	NULL
noteworthy	NULL
that	NULL
the	NULL
RA	NULL
action	NULL
on	NULL
adult	NULL
HPC	NULL
is	NULL
time	NULL
dependent	NULL
,	NULL
in	NULL
that	NULL
it	NULL
gradually	NULL
decreases	NULL
when	NULL
treatment	NULL
is	NULL
progressively	NULL
delayed	NULL
.	NULL

No	NULL
effect	NULL
is	NULL
observed	NULL
when	NULL
RA	NULL
is	NULL
added	NULL
on	NULL
day	NULL
6	NULL
through	NULL
8	NULL
.	NULL

Furthermore	NULL
,	NULL
a	NULL
6-hour	NULL
RA	NULL
pulse	NULL
E	NULL
d	NULL
0	NULL
d	NULL
2	NULL
d	NULL
5	NULL
d	NULL
9	NULL
£	NULL
``	NULL
Ap-	NULL
*	NULL
_j	NULL
=o	NULL
#	NULL
$	NULL
00	NULL
>	NULL
#	NULL
00	NULL
-	NULL
+-	NULL
RA	NULL
GaTA-1	NULL
«	NULL
itn	NULL
“	NULL
Bam	NULL
a	NULL
d	NULL
0	NULL
d	NULL
2	NULL
d	NULL
5	NULL
d	NULL
7	NULL
d	NULL
9	NULL
_	NULL
~*	NULL
A	NULL
*	NULL
``	NULL
``	NULL
ry	NULL
``	NULL
xy	NULL
»	NULL
``	NULL
``	NULL
x	NULL
=o	NULL
$	NULL
o	NULL
00	NULL
=	NULL
#	NULL
008	NULL
#	NULL
0	NULL
+-	NULL
RA	NULL
GATA-1	NULL
»	NULL
»	NULL
--	NULL
Bam	NULL
with	NULL
|	NULL
enous	NULL
-	NULL
Wake	NULL
Fig	NULL
5	NULL
.	NULL

RT-PCR	NULL
analysis	NULL
of	NULL
GATA	NULL
!	NULL

mRNA	NULL
expression	NULL
in	NULL
purified	NULL
HPCs	NULL
differentiating	NULL
in	NULL
the	NULL
unilineage	NULL
erythroid	NULL
or	NULL
granulocytic	NULL
liquid-culture	NULL
system	NULL
in	NULL
absence	NULL
or	NULL
presence	NULL
of	NULL
RA	NULL
.	NULL

#	NULL
,	NULL
m	NULL
represents	NULL
B	NULL
,	NULL
-microglobulin	NULL
internal	NULL
control	NULL
.	NULL

A	NULL
representative	NULL
experiment	NULL
is	NULL
shown	NULL
.	NULL

From	NULL
www.bloodjournal.org	NULL
by	NULL
guest	NULL
on	NULL
May	NULL
10	NULL
,	NULL
2019	NULL
.	NULL

For	NULL
personal	NULL
use	NULL
only	NULL
.	NULL

RETINOIC	NULL
ACID	NULL
INHIBITION	NULL
OF	NULL
ERYTHROPOIESIS	NULL
is	NULL
sufficient	NULL
to	NULL
induce	NULL
a	NULL
mild	NULL
inhibition	NULL
of	NULL
erythroid	NULL
proliferation	NULL
and	NULL
differentiation	NULL
,	NULL
whereas	NULL
a	NULL
24-	NULL
or	NULL
96-hour	NULL
pulse	NULL
treatment	NULL
induces	NULL
pronounced	NULL
effects	NULL
.	NULL

The	NULL
results	NULL
indicate	NULL
that	NULL
in	NULL
these	NULL
culture	NULL
conditions	NULL
,	NULL
RA	NULL
essentially	NULL
acts	NULL
at	NULL
the	NULL
early	NULL
HPC	NULL
level	NULL
.	NULL

Altogether	NULL
,	NULL
the	NULL
present	NULL
observations	NULL
may	NULL
be	NULL
compatible	NULL
with	NULL
those	NULL
reported	NULL
by	NULL
Douer	NULL
and	NULL
Koeffler	NULL
,	NULL
°	NULL
who	NULL
did	NULL
not	NULL
observe	NULL
an	NULL
inhibitory	NULL
effect	NULL
of	NULL
RA	NULL
on	NULL
erythroid-progenitor	NULL
colony	NULL
formation	NULL
;	NULL
indeed	NULL
,	NULL
these	NULL
investigators	NULL
utilized	NULL
unpu-rified	NULL
BM	NULL
HPCs	NULL
(	NULL
which	NULL
comprise	NULL
a	NULL
majority	NULL
of	NULL
late	NULL
erythroid	NULL
progenitors	NULL
and	NULL
a	NULL
minority	NULL
of	NULL
early	NULL
ones	NULL
)	NULL
supplemented	NULL
with	NULL
up	NULL
to	NULL
10~	NULL
``	NULL
mol/L	NULL
RA	NULL
in	NULL
FCS*	NULL
culture	NULL
.	NULL

It	NULL
may	NULL
be	NULL
suggested	NULL
that	NULL
the	NULL
action	NULL
of	NULL
RA	NULL
on	NULL
early	NULL
HPs	NULL
is	NULL
mediated	NULL
by	NULL
modulation	NULL
of	NULL
the	NULL
erythroid	NULL
and/or	NULL
granulocytic	NULL
differentiation	NULL
molecular	NULL
program	NULL
.	NULL

In	NULL
this	NULL
regard	NULL
,	NULL
the	NULL
master	NULL
gene	NULL
GATA1I	NULL
,	NULL
encoding	NULL
a	NULL
50-kD	NULL
finger	NULL
protein	NULL
,	NULL
regulates	NULL
erythroid-expressed	NULL
genes	NULL
through	NULL
core	NULL
GATA	NULL
motifs	NULL
and	NULL
is	NULL
required	NULL
for	NULL
normal	NULL
erythropoietic	NULL
development	NULL
,	NULL
as	NULL
shown	NULL
by	NULL
gene	NULL
targeting	NULL
in	NULL
embryonic	NULL
stem	NULL
cells	NULL
.	NULL
``	NULL

Whereas	NULL
aspects	NULL
of	NULL
GATAI	NULL
regulation	NULL
in	NULL
maturing	NULL
erythroid	NULL
cells	NULL
are	NULL
readily	NULL
reconciled	NULL
with	NULL
its	NULL
proposed	NULL
role	NULL
,	NULL
``	NULL
``	NULL
we	NULL
have	NULL
analyzed	NULL
its	NULL
expression	NULL
in	NULL
the	NULL
early	NULL
stages	NULL
of	NULL
hematopoiesis	NULL
,	NULL
ie	NULL
,	NULL
in	NULL
highly	NULL
purified	NULL
HPCs	NULL
induced	NULL
to	NULL
gradual	NULL
differentiation	NULL
specifically	NULL
along	NULL
the	NULL
erythrocytic	NULL
or	NULL
granulomonocytic	NULL
pathway	NULL
in	NULL
FCS~	NULL
liquid-suspension	NULL
culture	NULL
.	NULL
``	NULL

''	NULL
As	NULL
confirmed	NULL
here	NULL
,	NULL
the	NULL
GATA	NULL
!	NULL

gene	NULL
,	NULL
though	NULL
barely	NULL
expressed	NULL
in	NULL
the	NULL
early	NULL
quiescent	NULL
HPCs	NULL
,	NULL
is	NULL
activated	NULL
after	NULL
entrance	NULL
into	NULL
the	NULL
cell	NULL
cycle	NULL
upon	NULL
growth-factor	NULL
stimulus	NULL
;	NULL
subsequently	NULL
,	NULL
increasing	NULL
expression	NULL
along	NULL
the	NULL
erythroid	NULL
pathway	NULL
contrasts	NULL
with	NULL
downregulation	NULL
in	NULL
the	NULL
granulomonocytic	NULL
lineage	NULL
.	NULL
``	NULL

''	NULL
Hypo-thetically	NULL
,	NULL
on/off	NULL
switches	NULL
of	NULL
lineage-restricted	NULL
transactiva-tors	NULL
may	NULL
underlie	NULL
the	NULL
binary	NULL
fate	NULL
decisions	NULL
of	NULL
HPs	NULL
.	NULL
``	NULL

The	NULL
present	NULL
results	NULL
support	NULL
the	NULL
possibility	NULL
that	NULL
the	NULL
erythrocytic	NULL
to	NULL
granulocytic	NULL
shift	NULL
induced	NULL
by	NULL
RA	NULL
is	NULL
mediated	NULL
by	NULL
suppression	NULL
of	NULL
GATAIT	NULL
induction	NULL
in	NULL
the	NULL
erythroid	NULL
pathway	NULL
,	NULL
which	NULL
may	NULL
in	NULL
turn	NULL
lead	NULL
to	NULL
negative	NULL
regulation	NULL
of	NULL
the	NULL
Ep-receptor	NULL
promoter	NULL
.	NULL
``	NULL

It	NULL
is	NULL
noteworthy	NULL
that	NULL
both	NULL
embryonic	NULL
cells	NULL
and	NULL
adult	NULL
HPCs	NULL
are	NULL
characterized	NULL
by	NULL
a	NULL
striking	NULL
proliferative	NULL
and	NULL
differentiative	NULL
potential	NULL
that	NULL
may	NULL
involve	NULL
similar	NULL
growth	NULL
factors	NULL
(	NULL
eg	NULL
,	NULL
KL	NULL
,	NULL
IL-3	NULL
,	NULL
and	NULL
IL-6	NULL
)	NULL
.	NULL

``	NULL
°	NULL
Similarly	NULL
,	NULL
RA	NULL
may	NULL
hypothetically	NULL
function	NULL
as	NULL
both	NULL
a	NULL
morphogen	NULL
in	NULL
embryonic	NULL
de-velopment	NULL
,	NULL
``	NULL
and	NULL
a	NULL
modulator	NULL
in	NULL
early	NULL
adult	NULL
hematopoiesis	NULL
,	NULL
as	NULL
suggested	NULL
by	NULL
the	NULL
present	NULL
studies	NULL
.	NULL

ACKNOWLEDGMENT	NULL
We	NULL
thank	NULL
M.	NULL
Blasi	NULL
and	NULL
M.	NULL
Fontana	NULL
for	NULL
secretarial	NULL
assistance	NULL
,	NULL
R.	NULL
Negri	NULL
for	NULL
graphics	NULL
,	NULL
and	NULL
D.	NULL
Marinelli	NULL
for	NULL
editorial	NULL
help	NULL
.	NULL

REFERENCES	NULL
1	NULL
.	NULL

Mavilio	NULL
F	NULL
:	NULL
Regulation	NULL
of	NULL
homeo-box	NULL
containing	NULL
genes	NULL
by	NULL
morphogens	NULL
.	NULL

Eur	NULL
J	NULL
Biochem	NULL
212:273	NULL
,	NULL
1993	NULL
2	NULL
.	NULL

Deschamps	NULL
J	NULL
,	NULL
Meijlink	NULL
F	NULL
:	NULL
Mammalian	NULL
homeobox	NULL
genes	NULL
in	NULL
normal	NULL
development	NULL
and	NULL
neoplasia	NULL
.	NULL

Crit	NULL
Rev	NULL
One	NULL
3:1	NULL
17	NULL
,	NULL
1992	NULL
3	NULL
.	NULL

Lanotte	NULL
M	NULL
,	NULL
Martin-Thouvenin	NULL
V	NULL
,	NULL
Najman	NULL
S	NULL
,	NULL
Ballerini	NULL
P	NULL
,	NULL
Va-lensi	NULL
F	NULL
,	NULL
Berger	NULL
R	NULL
:	NULL
NB4	NULL
,	NULL
a	NULL
maturation	NULL
inducible	NULL
cell	NULL
line	NULL
with	NULL
t	NULL
(	NULL
15	NULL
;	NULL
17	NULL
)	NULL
marker	NULL
isolated	NULL
from	NULL
a	NULL
human	NULL
acute	NULL
promyelocytic	NULL
leukemia	NULL
(	NULL
M3	NULL
)	NULL
.	NULL

Blood	NULL
77:1080	NULL
,	NULL
1991	NULL
4	NULL
.	NULL

Breitman	NULL
TR	NULL
,	NULL
Selonick	NULL
SE	NULL
,	NULL
Collins	NULL
SJ	NULL
:	NULL
Induction	NULL
of	NULL
differentiation	NULL
of	NULL
the	NULL
human	NULL
promyelocytic	NULL
leukemia	NULL
cell	NULL
line	NULL
(	NULL
HL-60	NULL
)	NULL
by	NULL
retinoic	NULL
acid	NULL
.	NULL

Proc	NULL
Natl	NULL
Acad	NULL
Sci	NULL
USA	NULL
77:2936	NULL
,	NULL
1980	NULL
655	NULL
5	NULL
,	NULL
Valtieri	NULL
M	NULL
,	NULL
Boccoli	NULL
G	NULL
,	NULL
Testa	NULL
U	NULL
,	NULL
Barletta	NULL
C	NULL
,	NULL
Peschle	NULL
C	NULL
:	NULL
Two-step	NULL
differentiation	NULL
of	NULL
AML-193	NULL
leukemic	NULL
line	NULL
:	NULL
Terminal	NULL
maturation	NULL
is	NULL
induced	NULL
by	NULL
positive	NULL
interaction	NULL
of	NULL
retinoic	NULL
acid	NULL
with	NULL
granulo-cyte	NULL
colony-stimulating	NULL
factor	NULL
(	NULL
CSF	NULL
)	NULL
and	NULL
vitamin	NULL
D3	NULL
with	NULL
mono-cyte	NULL
CSF	NULL
.	NULL

Blood	NULL
77:1804	NULL
,	NULL
1991	NULL
6	NULL
.	NULL

Warrell	NULL
RP	NULL
,	NULL
Frankel	NULL
SR	NULL
,	NULL
Miller	NULL
W	NULL
,	NULL
Scheinberg	NULL
DA	NULL
,	NULL
Itri	NULL
LM	NULL
,	NULL
Hittelman	NULL
WN	NULL
,	NULL
Vyas	NULL
R	NULL
,	NULL
Andreeff	NULL
M	NULL
,	NULL
Tafuri	NULL
A	NULL
,	NULL
Jakybowski	NULL
A	NULL
,	NULL
Ga-brilove	NULL
J	NULL
,	NULL
Gordon	NULL
MS	NULL
,	NULL
Dimitrovsky	NULL
E	NULL
:	NULL
Differentiation	NULL
therapy	NULL
of	NULL
acute	NULL
promyelocytic	NULL
leukemia	NULL
with	NULL
tretinoin	NULL
(	NULL
all-trans-retinoic	NULL
)	NULL
.	NULL

N	NULL
Engl	NULL
J	NULL
Med	NULL
324	NULL
:	NULL
1385	NULL
,	NULL
1991	NULL
7	NULL
.	NULL

Tobler	NULL
A	NULL
,	NULL
Dawson	NULL
MI	NULL
,	NULL
Koeffler	NULL
HP	NULL
:	NULL
Retinoids	NULL
.	NULL

Structure-function	NULL
relationship	NULL
in	NULL
normal	NULL
and	NULL
leukemic	NULL
hematopoiesis	NULL
in	NULL
vitro	NULL
.	NULL

J	NULL
Clin	NULL
Invest	NULL
78:303	NULL
,	NULL
1986	NULL
8	NULL
.	NULL

Douer	NULL
D	NULL
,	NULL
Koeffler	NULL
P	NULL
:	NULL
Retinoic	NULL
acid	NULL
enhances	NULL
growth	NULL
of	NULL
human	NULL
early	NULL
erythroid	NULL
progenitor	NULL
cells	NULL
in	NULL
vitro	NULL
.	NULL

J	NULL
Clin	NULL
Invest	NULL
69:1039	NULL
,	NULL
1982	NULL
9	NULL
.	NULL

Schroeder	NULL
C	NULL
,	NULL
Gibson	NULL
L	NULL
,	NULL
Beug	NULL
H	NULL
:	NULL
The	NULL
v-erbA	NULL
oncogene	NULL
requires	NULL
cooperation	NULL
with	NULL
tyrosine	NULL
kinases	NULL
to	NULL
arrest	NULL
erythroid	NULL
differentiation	NULL
induced	NULL
by	NULL
ligand-activated	NULL
endogenous	NULL
c-erbA	NULL
and	NULL
retinoic	NULL
acid	NULL
receptor	NULL
.	NULL

Oncogene	NULL
7:203	NULL
,	NULL
1992	NULL
10	NULL
.	NULL

Peschle	NULL
C	NULL
,	NULL
Testa	NULL
U	NULL
,	NULL
Caré	NULL
A	NULL
,	NULL
Valtieri	NULL
M	NULL
,	NULL
Gabbianelli	NULL
M	NULL
,	NULL
Pelosi	NULL
E	NULL
,	NULL
Montesoro	NULL
E	NULL
,	NULL
Sposi	NULL
NM	NULL
,	NULL
Fossati	NULL
C	NULL
,	NULL
Camagna	NULL
A	NULL
:	NULL
Stringently	NULL
purified	NULL
human	NULL
hematopoietic	NULL
progenitors/stem	NULL
cells	NULL
:	NULL
Analysis	NULL
of	NULL
cellular/molecular	NULL
mechanisms	NULL
underlying	NULL
early	NULL
hematopoiesis	NULL
.	NULL

Stem	NULL
Cells	NULL
1	NULL
1:356	NULL
,	NULL
1993	NULL
11	NULL
.	NULL

Caré	NULL
A	NULL
,	NULL
Testa	NULL
U	NULL
,	NULL
Bassani	NULL
A	NULL
,	NULL
Tritarelli	NULL
E	NULL
,	NULL
Montesoro	NULL
E	NULL
,	NULL
Sa-moggia	NULL
P	NULL
,	NULL
Cianetti	NULL
L	NULL
,	NULL
Peschle	NULL
C	NULL
:	NULL
Coordinate	NULL
expression	NULL
and	NULL
permissive	NULL
proliferative	NULL
role	NULL
of	NULL
HOXB	NULL
genes	NULL
in	NULL
activated	NULL
adult	NULL
T	NULL
lympho-cytes	NULL
.	NULL

(	NULL
submitted	NULL
)	NULL
12	NULL
.	NULL

Garbe	NULL
A	NULL
,	NULL
Buck	NULL
J	NULL
,	NULL
Hammerling	NULL
U	NULL
:	NULL
Retinoids	NULL
are	NULL
important	NULL
cofactors	NULL
in	NULL
T	NULL
cell	NULL
activation	NULL
.	NULL

J	NULL
Exp	NULL
Med	NULL
176:109	NULL
,	NULL
1992	NULL
13	NULL
.	NULL

Buck	NULL
J	NULL
,	NULL
Derguini	NULL
F	NULL
,	NULL
Levi	NULL
E	NULL
,	NULL
Nakanishi	NULL
K	NULL
,	NULL
Hammerling	NULL
U	NULL
:	NULL
Intracellular	NULL
signaling	NULL
by	NULL
14-hydroxy-4	NULL
,	NULL
14-retroretinol	NULL
.	NULL

Science	NULL
154	NULL
;	NULL
1654	NULL
,	NULL
1991	NULL
14	NULL
.	NULL

Blomhoff	NULL
HK	NULL
,	NULL
Smeland	NULL
EB	NULL
,	NULL
Erikstein	NULL
B	NULL
,	NULL
Rasmusser	NULL
AM	NULL
,	NULL
Strede	NULL
B	NULL
,	NULL
Skjonsberg	NULL
C	NULL
,	NULL
Blomhoff	NULL
E	NULL
:	NULL
Vitamin	NULL
A	NULL
is	NULL
a	NULL
key	NULL
regulator	NULL
for	NULL
cell	NULL
growth	NULL
,	NULL
cytokine	NULL
production	NULL
and	NULL
differentiation	NULL
in	NULL
normal	NULL
B	NULL
cells	NULL
.	NULL

J	NULL
Biol	NULL
Chem	NULL
267:23988	NULL
,	NULL
1992	NULL
15	NULL
.	NULL

Gabbianelli	NULL
M	NULL
,	NULL
Sargiacomo	NULL
M	NULL
,	NULL
Pelosi	NULL
E	NULL
,	NULL
Testa	NULL
U	NULL
,	NULL
Peschle	NULL
C	NULL
:	NULL
Pure	NULL
human	NULL
hematopoietic	NULL
progenitors	NULL
:	NULL
Permissive	NULL
action	NULL
of	NULL
basic	NULL
fibroblast	NULL
growth	NULL
factor	NULL
.	NULL

Science	NULL
249	NULL
:	NULL
1561	NULL
,	NULL
1990	NULL
16	NULL
.	NULL

Boyum	NULL
A	NULL
:	NULL
A	NULL
separation	NULL
of	NULL
leukocytes	NULL
from	NULL
blood	NULL
and	NULL
bone	NULL
marrow	NULL
.	NULL

Scand	NULL
J	NULL
Clin	NULL
Lab	NULL
Invest	NULL
27:77	NULL
,	NULL
1968	NULL
(	NULL
suppl	NULL
42	NULL
)	NULL
17	NULL
.	NULL

Peschle	NULL
C	NULL
,	NULL
Gabbianelli	NULL
M	NULL
,	NULL
Testa	NULL
U	NULL
,	NULL
Pelosi	NULL
E	NULL
,	NULL
Barberi	NULL
T	NULL
,	NULL
Valtieri	NULL
M	NULL
,	NULL
Leone	NULL
L	NULL
:	NULL
c-Kit	NULL
ligand	NULL
reactivates	NULL
HbF	NULL
synthesis	NULL
in	NULL
serum-free	NULL
cultures	NULL
of	NULL
purified	NULL
normal	NULL
adult	NULL
BFU-E	NULL
.	NULL

Blood	NULL
81:326	NULL
,	NULL
1993	NULL
18	NULL
.	NULL

Valtie	NULL
M	NULL
,	NULL
Gabbianelli	NULL
M	NULL
,	NULL
Pelosi	NULL
E	NULL
,	NULL
Bassano	NULL
E	NULL
,	NULL
Petti	NULL
S	NULL
,	NULL
Russo	NULL
G	NULL
,	NULL
Testa	NULL
U	NULL
,	NULL
Peschle	NULL
C	NULL
:	NULL
Erythropoietin	NULL
alone	NULL
induces	NULL
erythroid	NULL
burst	NULL
formation	NULL
by	NULL
human	NULL
embryonic	NULL
but	NULL
not	NULL
adult	NULL
BFU-E	NULL
in	NULL
unicellular	NULL
serum-free	NULL
culture	NULL
.	NULL

Blood	NULL
74:460	NULL
,	NULL
1989	NULL
19	NULL
.	NULL

Eliason	NULL
J	NULL
:	NULL
Granulocyte-macrophage	NULL
colony-formation	NULL
in	NULL
serum-free	NULL
culture	NULL
:	NULL
Effects	NULL
of	NULL
purified	NULL
colony-stimulating	NULL
factors	NULL
and	NULL
modulation	NULL
by	NULL
hydrocortisone	NULL
.	NULL

J	NULL
Cell	NULL
Physiol	NULL
128:231	NULL
,	NULL
1986	NULL
20	NULL
.	NULL

Sposi	NULL
NM	NULL
,	NULL
Zon	NULL
LI	NULL
,	NULL
Caré	NULL
A	NULL
,	NULL
Valtieri	NULL
M	NULL
,	NULL
Testa	NULL
U	NULL
,	NULL
Gabbianelli	NULL
M	NULL
,	NULL
Mariani	NULL
G	NULL
,	NULL
Bottero	NULL
L	NULL
,	NULL
Mather	NULL
C	NULL
,	NULL
Orkin	NULL
SH	NULL
,	NULL
Peschle	NULL
C	NULL
:	NULL
Cycle-dependent	NULL
initiation	NULL
and	NULL
lineage-dependent	NULL
abrogation	NULL
of	NULL
GATA1	NULL
expression	NULL
in	NULL
pure	NULL
differentiating	NULL
hematopoietic	NULL
progenitors	NULL
.	NULL

Proc	NULL
Natl	NULL
Acad	NULL
Sci	NULL
USA	NULL
89:6353	NULL
,	NULL
1992	NULL
21	NULL
.	NULL

Chirgwin	NULL
M	NULL
,	NULL
Pezybyla	NULL
AE	NULL
,	NULL
MacDonald	NULL
RJ	NULL
,	NULL
Rutter	NULL
WT	NULL
:	NULL
Isolation	NULL
of	NULL
biologically	NULL
active	NULL
ribonucleic	NULL
acid	NULL
from	NULL
sources	NULL
enriched	NULL
in	NULL
ribonuclease	NULL
.	NULL

Biochemistry	NULL
18:5294	NULL
,	NULL
1979	NULL
22	NULL
.	NULL

Warrel	NULL
RP	NULL
Jr	NULL
,	NULL
De	NULL
The	NULL
H	NULL
,	NULL
Wang	NULL
Z	NULL
,	NULL
Degos	NULL
L	NULL
:	NULL
Acute	NULL
promyelocytic	NULL
leukemia	NULL
.	NULL

N	NULL
Engl	NULL
J	NULL
Med	NULL
329:177	NULL
,	NULL
1992	NULL
23	NULL
.	NULL

Muindi	NULL
J	NULL
,	NULL
Frankel	NULL
SR	NULL
,	NULL
Miller	NULL
WH	NULL
,	NULL
Jakubowski	NULL
A	NULL
,	NULL
Scheinberg	NULL
DA	NULL
,	NULL
Young	NULL
CW	NULL
,	NULL
Dmitrovsky	NULL
E	NULL
,	NULL
Warrel	NULL
RP	NULL
Jr	NULL
:	NULL
Continuous	NULL
treatment	NULL
with	NULL
all-trans	NULL
retinoic	NULL
acid	NULL
causes	NULL
a	NULL
progressive	NULL
reduction	NULL
in	NULL
plasma	NULL
drug	NULL
concentrations	NULL
:	NULL
Implications	NULL
for	NULL
relapse	NULL
and	NULL
reti-	NULL
From	NULL
www.bloodjournal.org	NULL
by	NULL
guest	NULL
on	NULL
May	NULL
10	NULL
,	NULL
2019	NULL
.	NULL

For	NULL
personal	NULL
use	NULL
only	NULL
.	NULL

656	NULL
noid	NULL
``	NULL
resistance	NULL
``	NULL
in	NULL
patients	NULL
with	NULL
acute	NULL
promyelocytic	NULL
leukemia	NULL
.	NULL

Blood	NULL
79:299	NULL
,	NULL
1992	NULL
24	NULL
.	NULL

Gudas	NULL
LT	NULL
:	NULL
Retinoids	NULL
,	NULL
retinoid-responsive	NULL
genes	NULL
,	NULL
cell	NULL
differentiation	NULL
and	NULL
cancer	NULL
.	NULL

Cell	NULL
Growth	NULL
Differ	NULL
3:655	NULL
,	NULL
1992	NULL
25	NULL
.	NULL

Brief	NULL
Critical	NULL
Reviews	NULL
.	NULL

All-trans	NULL
and	NULL
13-cis-retinoic	NULL
acids	NULL
are	NULL
normal	NULL
constituents	NULL
of	NULL
human	NULL
blood	NULL
formed	NULL
from	NULL
all-trans-retinyl-palmitate	NULL
.	NULL

Nutr	NULL
Rev	NULL
49:283	NULL
,	NULL
1991	NULL
26	NULL
.	NULL

Evans	NULL
RM	NULL
:	NULL
The	NULL
steroid	NULL
and	NULL
thyroid	NULL
hormone	NULL
receptor	NULL
super-family	NULL
.	NULL

Science	NULL
240:889	NULL
,	NULL
1988	NULL
27	NULL
.	NULL

Pevny	NULL
L	NULL
,	NULL
Simon	NULL
MC	NULL
,	NULL
Robertson	NULL
E	NULL
,	NULL
Klein	NULL
WH	NULL
,	NULL
Tsai	NULL
SF	NULL
,	NULL
LABBAYE	NULL
ET	NULL
AL	NULL
D'Agati	NULL
V	NULL
,	NULL
Orkin	NULL
SH	NULL
,	NULL
Costantini	NULL
F	NULL
:	NULL
Erythroid	NULL
differentiation	NULL
in	NULL
chi-maeric	NULL
mice	NULL
blocked	NULL
by	NULL
a	NULL
targeted	NULL
mutation	NULL
in	NULL
the	NULL
gene	NULL
for	NULL
transcription	NULL
factor	NULL
GATA	NULL
.	NULL

Nature	NULL
349:257	NULL
,	NULL
1991	NULL
28	NULL
.	NULL

Orkin	NULL
SH	NULL
.	NULL

GATA-binding	NULL
transcription	NULL
factors	NULL
in	NULL
hematopoietic	NULL
cells	NULL
.	NULL

Blood	NULL
80:575	NULL
,	NULL
1992	NULL
29	NULL
.	NULL

Zon	NULL
LI	NULL
,	NULL
Youssoufian	NULL
H	NULL
,	NULL
Mather	NULL
C	NULL
,	NULL
Lodish	NULL
HF	NULL
,	NULL
Orkin	NULL
SH	NULL
:	NULL
Activation	NULL
of	NULL
the	NULL
erythropoietin	NULL
receptor	NULL
promoter	NULL
by	NULL
transcription	NULL
factor	NULL
GATA-1	NULL
.	NULL

Proc	NULL
Natl	NULL
Acad	NULL
Sci	NULL
USA	NULL
88:10638	NULL
,	NULL
1991	NULL
30	NULL
.	NULL

Jessel	NULL
TM	NULL
,	NULL
Melton	NULL
DA	NULL
:	NULL
Diffusible	NULL
factors	NULL
in	NULL
vertebrate	NULL
embryonic	NULL
induction	NULL
.	NULL

Cell	NULL
68:257	NULL
,	NULL
1992	NULL
From	NULL
www.bloodjournal.org	NULL
by	NULL
guest	NULL
on	NULL
May	NULL
10	NULL
,	NULL
2019	NULL
.	NULL

For	NULL
personal	NULL
use	NULL
only	NULL
.	NULL

blO	NULL
Od®	NULL
1994	NULL
83	NULL
:	NULL
651-656	NULL
Retinoic	NULL
acid	NULL
downmodulates	NULL
erythroid	NULL
differentiation	NULL
and	NULL
GATA1	NULL
expression	NULL
in	NULL
purified	NULL
adult-progenitor	NULL
culture	NULL
4	NULL
_	NULL
5	NULL
,	NULL
'	NULL
_	NULL
>	NULL
,	NULL
#	NULL
04	NULL
;	NULL
©1004	NULL
@	NULL
207	NULL
C	NULL
Labbaye	NULL
,	NULL
M	NULL
Valtieri	NULL
,	NULL
U	NULL
Testa	NULL
,	NULL
A	NULL
Giampaolo	NULL
,	NULL
E	NULL
Meccia	NULL
,	NULL
P	NULL
Sterpetti	NULL
,	NULL
|	NULL
Parolini	NULL
,	NULL
E	NULL
Pelosi	NULL
,	NULL
D	NULL
Bulgarini	NULL
and	NULL
YE	NULL
Cayre	NULL
Updated	NULL
information	NULL
and	NULL
services	NULL
can	NULL
be	NULL
found	NULL
at	NULL
:	NULL
http	NULL
:	NULL
//www.bloodjournal.org/content/83/3/651	NULL
.full.html	NULL
Articles	NULL
on	NULL
similar	NULL
topics	NULL
can	NULL
be	NULL
found	NULL
in	NULL
the	NULL
following	NULL
Blood	NULL
collections	NULL
Information	NULL
about	NULL
reproducing	NULL
this	NULL
article	NULL
in	NULL
parts	NULL
or	NULL
in	NULL
its	NULL
entirety	NULL
may	NULL
be	NULL
found	NULL
online	NULL
at	NULL
:	NULL
requests	NULL
Information	NULL
about	NULL
ordering	NULL
reprints	NULL
may	NULL
be	NULL
found	NULL
online	NULL
at	NULL
:	NULL
http	NULL
:	NULL
//www.bloodjournal.org/site/misc/rights.xhtml	NULL
#	NULL
reprints	NULL
Information	NULL
about	NULL
subscriptions	NULL
and	NULL
ASH	NULL
membership	NULL
may	NULL
be	NULL
found	NULL
online	NULL
at	NULL
:	NULL
http	NULL
:	NULL
//www.bloodjournal.org/site/subscriptions/index.xhtml	NULL
Blood	NULL
(	NULL
print	NULL
ISSN	NULL
0006-4971	NULL
,	NULL
online	NULL
ISSN	NULL
1528-0020	NULL
)	NULL
,	NULL
is	NULL
published	NULL
weekly	NULL
by	NULL
the	NULL
American	NULL
Society	NULL
of	NULL
Hematology	NULL
,	NULL
2021	NULL
L	NULL
St	NULL
,	NULL
NW	NULL
,	NULL
Suite	NULL
900	NULL
,	NULL
Washington	NULL
DC	NULL
20036	NULL
.	NULL

Copyright	NULL
2011	NULL
by	NULL
The	NULL
American	NULL
Society	NULL
of	NULL
Hematology	NULL
;	NULL
all	NULL
rights	NULL
reserved	NULL
.	NULL

